{
    "id": "kbm26mwgpkkybhv24jkcrx4kwjbg2hhk",
    "title": "Slowly but surely, Bayesian ideas revolutionize medical research",
    "info": {
        "author": [
            "Donald A. Berry, University of Texas M.D. Anderson Cancer Center, University of Texas at Austin"
        ],
        "introducer": [
            "Peter Mueller, University of Texas M.D. Anderson Cancer Center, University of Texas at Austin"
        ],
        "recorded by": [
            "Kyoeisha"
        ],
        "published": "Aug. 22, 2012",
        "recorded": "June 2012",
        "category": [
            "Top->Mathematics->Statistics"
        ]
    },
    "url": "http://videolectures.net/isba2012_berry_bayesian_ideas/",
    "segmentation": [
        [
            "Next is my lecture, which should really be titled slowly but surely danbarry revolutionizes medical research.",
            "It's a real privilege to introduce the speaker for our next lecture.",
            "Danbarry over the last 1520 years and more.",
            "Has been relentlessly working on introducing.",
            "Innovative, coherent, wonderful vision ideas.",
            "An the research and planning for clinical studies and has made a lot of difference in doing so.",
            "And will tell us some of the exciting success stories now please thank you, Peter, and thanks to the organizers.",
            "It's been a bit more than 15 years.",
            "So I'm going to talk about mainly about designing experiments from a Bayesian perspective.",
            "When is, but was formed.",
            "I argued to the powers that were that the Bayesian approach was more important.",
            "In designing experiments then and analyzing them, I tried to get them to incorporate the word design in addition to analysis.",
            "So for example, the International Society of Bayesian analysis and design.",
            "But the acronym didn't work, so we're left without the design, but you'll get some today.",
            "So this is a rough year."
        ],
        [
            "Tree Biostatistics, very rough.",
            "In the 1800s, in the early 1900s, there was a continual tug between those who said.",
            "You should.",
            "You should pay attention to the data you treat a patient and you gotta take take into consideration what happens to that patient and put together lots of patients and to draw a conclusion as to whether the treatment is effective.",
            "Against the attitude among physicians that this is my patient, my patient is unique.",
            "I know my patient.",
            "And you can't tell me how to treat my patient.",
            "That attitude I talked about it as being nineteen, 1800s and 1900s persists today.",
            "I I was testifying to Congress to a Senate committee Bill Frist, who at the time was the Senate Majority Leader was on the panel and asking me his five minutes to ask me questions and he spent his five minutes telling me and everybody else that he was an MD.",
            "And I wasn't.",
            "I notice the WR, Thompson and Bays in 1933.",
            "In a series of papers, he laid out a Bayesian approach to clinical trials.",
            "And it was really quite neat.",
            "It was very interesting because in his 1933 biometrika paper, the first page.",
            "Said everything that anybody was interested in, and the next 10 pages talked about how you could compute incomplete beta functions.",
            "Of course, today it's just you plug into the computer, sometimes doing simulations to get the answer, but the core was in at 1st and I'll talk a little bit about that.",
            "In 1997, the frequentist half century that's critical, so in the 1940s Bradford Bradford Hill discovered, founded, put forth the notion of randomization course.",
            "Randomization goes back to least Fisher in the context of agricultural experiments and Bradford Hill in the 1940s suggested it in clinical trials.",
            "And is widely regarded as being the father of randomized clinical trials.",
            "That established the level of evidence that we are that the medical profession continues to be in reference of an the.",
            "Second half of the 19th of the 18th.",
            "I'll get it right.",
            "The 20th century was what I called a frequentist half century, essentially knowbase.",
            "There were a few people crying in the wilderness like me.",
            "I it during this.",
            "I was on the train in Washington DC and somebody from the FDA came up to me and said, you know, Don, I've, I've heard you talk about Bayes approaches many times and every time I hear you, I become a Bayesian.",
            "For 10 minutes.",
            "So ever since then, I've been working on a sustained relief version.",
            "His sustained, released version.",
            "So now."
        ],
        [
            "1897 There was a Turning point Congress in the United States was pushing the FDA, too.",
            "Take it easy on medical device companies asking them to do these huge trials didn't make sense and there were there.",
            "There's something like 30,000 medical device companies in the world and there is about 1000 or less pharmaceutical companies and pharmaceutical and getting smaller all the time as they gobble each other up.",
            "And the medical device companies sometimes don't have statisticians frequently don't they?",
            "Don't.",
            "They can't afford to run clinical trials.",
            "So Congress passed the so-called fadama.",
            "the FDA Modernization Act, and they used the term least burdensome, and that term was taken by the FDA as be Bayesian.",
            "And since then I'll tell you about some of the rest of that story, so this is."
        ],
        [
            "To be personal and I'll tell you about my exposures overtime to the medical world and how I've tried to impact the way people think about things in 1970 in my dissertation I talked about bandit problems, design of an experiment.",
            "Yeah, you probably don't know what they are, so let me let me give you a very simple example.",
            "You have two coins.",
            "You don't know the probabilities of heads on either coin.",
            "I tell you that you can toss a coin.",
            "Every time between the two, every time you get heads, I'll give you a dollar.",
            "Every time you get tails you get nothing.",
            "And I'll give you 100 tosses so you can make a maximum of $100.",
            "Or yen, although I guess he'd rather make $100.",
            "And you get to look at the results.",
            "So you take a coin, you toss it, you get heads.",
            "You want a dollar, but you also get information that this coin is pretty good.",
            "You might say, well, I'll use it again.",
            "You use it again and you get heads.",
            "It's looking even better, so driven you use it again, you get tails.",
            "Now it's not looking too bad.",
            "You know two out of three ain't bad.",
            "Who is it was a song, two or three?",
            "But there's this other coin that's sitting there untried.",
            "And maybe it's better.",
            "Which one is the optimal one to use?",
            "Is it the first one or the second one?",
            "You have 97 more tosses to go.",
            "I claim it's not an easy problem and where's my quest?",
            "The solution is by dynamic programming or backward induction.",
            "Depends on the prior distribution that you had.",
            "If, for example, I'll just tell you the answer.",
            "If there are uniform on both independent uniform on both, the answer is you use the one that gave two out of three.",
            "But if you lose the next time, you definitely want to switch.",
            "1980 is something I have to tell you about myself.",
            "I have six kids and I was on the faculty of the University of Minnesota and they were making even less money than they are today, which is not much.",
            "And so I started consulting for what is now 3M Laboratories and I sort of learned the hard way.",
            "But what medical research was about?",
            "I thought that this you know, bandit problems, that's the way they run.",
            "Clinical trials you learn as you go and you try to treat patients effectively with time.",
            "I reminded Peter and I, Peter Mueller, and I designed a trial for Pfizer about 15 years ago.",
            "Stroke it was Bayesian through and through.",
            "We worked hard at it, designed a great trial.",
            "When I attracted Peter to come to MD Anderson.",
            "He started to see the way other trials were designed and he said, you know, Don.",
            "I thought every trial was like the trial we designed for Pfizer and I'm learning that they are pretty dumb.",
            "So my reaction was the same when I went to Duke I was asked to participate in something called a CLG beta cancer and leukemia Group B, which is a national oncology group.",
            "Anne was assigned breast cancer.",
            "High in the 1980s I helped in 1990s I helped the FDA with their Bayesian Initiative 1997.",
            "I happened to serve on a consensus development conference with the NIH National Institutes of Health on Screening Mammography for women in their 40s.",
            "I was Co chair of the panel, and I'll tell you a little bit about that.",
            "1999 went to MD Anderson.",
            "And we've designed lots of trials from a Bayesian perspective, and I'll mention that as well."
        ],
        [
            "In 2015 were coming around, and so it's you know it's it's the hitting the circuit here and I think we're coming back to bandit problems.",
            "By the way, I should say that it isn't only in medicine.",
            "I don't know if Steve Scott is at this.",
            "Conference, but Steve works at Google and they are heavily into bandit problems.",
            "You know, when you Google something.",
            "There are some advertisements on the side.",
            "Every time you click an ad.",
            "Google makes money.",
            "What they want you to do is to click the ad and there are ways there are various kinds of ads that they can put on the thing to attract you.",
            "You know they can put a blue background with, say, three watch is or a single watch that looks like a Rolex.",
            "Or they're selling watches or a woman with low cleavage wearing a watch or not.",
            "They want you to hit, but they can experiment.",
            "And they know when you're looking at it and you don't hit, so they know the denominator.",
            "How should they configure so as to maximize their profit over the long term?",
            "It's a bandit problem, it's a multi armed bandit problem where they've got all kinds of possibilities for configuring the ad."
        ],
        [
            "Five top three reasons for Bayes.",
            "And one of the things you don't see here in the Bio Statistical area is subjective probability and measures that use the data in an appropriate way.",
            "That sort of implicit in some of these, but online learning.",
            "So you see it, you see something and you take advantage of it, something that hasn't been done heretofore in Biostatistics predicted probabilities.",
            "So we when we design trials.",
            "Very consultants.",
            "When we design trials we use we everything is predictive.",
            "Where are we going?",
            "And do we want to go there?",
            "Or do we want to change the trial design?",
            "Not that we you know, this is all done prospectively, or do we want to change and go in a different direction?",
            "Again, every direction is prospectively described modeling hierarchical modeling.",
            "Modeling quite generally and decision and."
        ],
        [
            "This is so somebody, but I asked about genetic, so several examples in genetics.",
            "In paternity testing, which is down near the bottom here.",
            "I testify when when I was in Minnesota in a number of cases of paternity suits.",
            "And the way they did the calculations, you know they had like say 10 genes an in father mother and child and they would multiply everything together, which is not necessarily right, but they come up with a number which is essentially a likelihood ratio, and then they would say this is the likely they would convert that into a probability, and that this is the likelihood of paternity.",
            "Or after I complained about it.",
            "The Blood bank started to use the plausibility of paternity.",
            "What it was was the posterior probability of paternity.",
            "Assuming that every man had a 50% chance of being the father.",
            "So they just converted the likelihood ratio into into an odds ratio and it didn't matter that they had three men, all of whom had, you know, 50% or more.",
            "And that led to the ancestry for.",
            "Corn, soybeans cattle Cabernet Sauvignon the model that I built that I'll tell you a little bit about was used to show that Cabernet Sauvignon.",
            "Is in fact a descendant of centuries old descendant of Cabernet Franc and Sauvignon Blanc.",
            "DNA fingerprinting, BRCA pro doping.",
            "I'll tell you about these."
        ],
        [
            "So this is a.",
            "A series of papers that I wrote with Ian Evatt and the UK at the time, the Home Office Forensic Science Service where we did Bayesian things an we incorporated.",
            "And and what they did was they in the DNA profiling.",
            "They looked at fragment lengths and they would multiply the probabilities associated with the fragment lengths.",
            "Assuming independence, which was absolutely not true.",
            "So what this thing does is reckons with the correlations among the data."
        ],
        [
            "When I was at Duke Giovanni Parmigiani and I, along with others at Iverson, Omar Aguilar built a model that's still used today.",
            "In fact, it's the most commonly used model for assessing the probability of carrier status of that somebody carries a mutation of BRCA, one breast cancer gene or BRCA two based on family history.",
            "Of.",
            "Breast cancer, ovarian cancer, and some other cancers.",
            "And this is a paper.",
            "This was a validation of it that concluded BRCA Pro marries Mendel and Bayes.",
            "It uses the hereditary characteristics and incorporates the Bayesian modeling of various steps in the probability line.",
            "You can do it analytically if the family is small, but you have to do something like simulation of the family is larger if you're considering lots of.",
            "Different kinds of cancers, different ages, which patients have had cancers or not, and we."
        ],
        [
            "Included in this one paper or BRCA pros.",
            "Accurate genetic testing for BRCA one and BRCA two is highly sensitive.",
            "Missing an estimated 15% of mutations.",
            "I've been telling people at Duke and otherwise that stop looking for BRCA 3.",
            "It doesn't exist if it exists.",
            "There's only a small penetrance.",
            "There's only a small proportion of the patients who have it, or it elevates the risk of breast cancer only slightly.",
            "And so this is 15 years ago.",
            "And I couldn't convince people and they continue to look for BRCA three and the update for you today.",
            "Is that nobody is yet found the BRCA 3.",
            "These were the data that I based that on."
        ],
        [
            "So this is the BRCA pro probability.",
            "With you know sets of people 60 in each group.",
            "Then look to see how many were actually positive.",
            "This is predicting whether you carrying this mutation and down in the lower reaches.",
            "We were underestimating and in the higher reaches we were overestimating.",
            "It's improved since this was over 10 years ago.",
            "But you'll notice that up here we are uniformly.",
            "Undershooting and so there is.",
            "There's something there that we're missing could be more mutations on the same gene.",
            "It could be other jeans and so, but it's not much, and that was the point."
        ],
        [
            "In five years ago or so I wrote this paper for nature commentary called the Science of doping, or lack thereof.",
            "Pictures of Floyd Landis in the 2006 Tour de France.",
            "And.",
            "I complained about the science at the World Anti Doping Agency water saying that it essentially didn't exist.",
            "And things haven't changed.",
            "Just last week I was in Lausanne, Switzerland.",
            "A scientific council for a case involving human growth hormone.",
            "And you probably read about this sort of stuff back with Floyd Landis.",
            "And in those days it was testosterone.",
            "The doping dujour is human growth hormone.",
            "And water has a test for it.",
            "Tell you about one example of a statistical calculation that they make.",
            "Here's what they do.",
            "They look at what individuals cases that they run in the course of the various events they look at, what their growth hormone was.",
            "So you can imagine that there is a big clump of values of the growth hormone, and then there's a smattering of higher values.",
            "So here's what they do.",
            "They say those higher values must be users.",
            "The ones in the middle are not users.",
            "So they said we're going to take those and go to fit a distribution.",
            "And the distribution, it looks like it fits best is the lognormal.",
            "And then they take the 99.99 percentile of the lognormal and call that the cut point, and they say we have a one in 10,000.",
            "Chance of a false positive.",
            "You see 99.991 minus.",
            "The rub is.",
            "That the data that they had for normals totaled 140 cases.",
            "None of which was bigger than the cut point because they had cut the tail of the distribution.",
            "So here's what they did.",
            "If in effect they cut off the tail.",
            "And then said look, it has a small tail.",
            "Anyway, the science is abysmal, and that's just one example.",
            "Are a point of oh, I should have critical issue here.",
            "This was the penultimate version at the 11th hour.",
            "Nature.",
            "Got spooked by the possibility that was real, actually, that WADA would Sue them for publishing this article, and so right at the."
        ],
        [
            "11th hour they took our lack thereof off.",
            "One of the things I talk about in the."
        ],
        [
            "Articles of prosecutors fallacy.",
            "The here's what they do.",
            "They conclude that if you have a very small chance of something.",
            "That you must be guilty with probability 1 minus that.",
            "So they are mixing up, you know they're inverting the conditional, and I explained that this you have to use Bayes rule to do that.",
            "If you want to read more about the prosecutors fallacy, Google, Mark Buchanan the prosecutors fallacy.",
            "It'll take you to a New York Times article by Buchanan about a woman named on the Burke from the Netherlands who had the misfortune of being in the operating room when lots of patients died.",
            "She was tried.",
            "On the basis of the rarity of the confluence of all of those things, and a very small probability that this was going to happen, and therefore she was guilty.",
            "When I wrote this article, I cited Buchanan.",
            "And the editor said no, I want to take that off.",
            "I said why?",
            "It's an elegant paper.",
            "He said that's the problem.",
            "He writes better than you do.",
            "If you want to see something another elegant presentation, Google Peter Donnelly in the Ted Conference and he'll tell you about a similar case.",
            "Sally Clark in UK that was convicted of killing two of her kids who died of SIDS.",
            "Sudden, sudden infant death syndrome in UK they called Crib Death.",
            "And this doesn't happen.",
            "Very often and they calculated a probability of one in 70 some million that it happens and therefore she's guilty.",
            "Now mind you, here's an instance where we don't even know there was a crime, just like with on a divert.",
            "Anyway, Donnelly does a terrific job explaining this and it in telling you how a pediatrician is doing statistics and would you go over a bridge if you knew that this pediatrician had built the bridge?",
            "Is it anyway?",
            "Anish."
        ],
        [
            "Issue that's very difficult to describe.",
            "To get people to understand in the 2006 Tour de France because Landis wrote one several of the heats and was the leader obviously was the winner.",
            "At the end he had more tests than anybody else.",
            "He had eight of the 126 Tests that had been done.",
            "So it's multiplicity.",
            "You know if you do things enough, you'll see unusual things and incorporate according incorporating that into the analysis is something that can and should be done.",
            "I.",
            "You know this is strategy like issues of strategy.",
            "Suppose you're a bicyclist.",
            "And suppose you know the law is correct that lots of these bicyclists are using dope.",
            "You know that if someone so gets tested these times, he's probably going to be illuminated.",
            "And so you, because you're, you know, mediocre bicyclists aren't going to be tested at all.",
            "And so you know, if you lay back.",
            "Maybe the people that come in ahead of you will all be eliminated and you win.",
            "It's not a fair policy, it's hard to complain about in any particular instance, but it's not fair, but it's absolutely standard.",
            "If you're good, you get tested a lot.",
            "This was."
        ],
        [
            "An example Gan genetics.",
            "It was a consulting project for pioneer seeds, which is now part of DuPont where they had cases where their germplasm was being stolen, so they make they have corn seeds for example they sell to farmers.",
            "Farmers put it in the ground and it grows what they sell or hybrids.",
            "These are things that are bred in such a way that it's very uniform.",
            "So when you look at the the rows of corn, they're all the same height.",
            "And people have been stealing their germplasm in several ways.",
            "The cutest way is the way.",
            "The corn is bread.",
            "The way it sits.",
            "The corn seeds are our bread for putting in the bags, and the farmer buys is you take 2 inbreds.",
            "The hybrid is a cross between two inbreds.",
            "The inbreds are essentially all homozygous.",
            "So whenever you put to him together you get the same thing.",
            "And the way they grow these things is they they don't want the the self germination.",
            "So they hire high school kids for example, to go through the fields and everybody who is, you know the one inbred.",
            "The female inbred you pull the tusks off so it can't breed itself.",
            "Kasian Lee they miss and so occasionally the inbred breeds itself an this Colonel in the bag of corn.",
            "Comes from that matching.",
            "So what the competitors do and this is against the law is they.",
            "There's a bag tag rule is they buy bags of pioneer seeds and they plan.",
            "And almost all of the corn is uniformly high.",
            "Maybe all of it is uniformly, but occasionally there's this runt.",
            "The runt is the inbred.",
            "It's the, it's the Crown jewels and so they take that one now.",
            "If they use that and they did genetic analysis, it would be clear that they had stolen it.",
            "So what they do is they take it and they made it with some other similar inbred to get you know genetic variation variation and then they self it out.",
            "They essentially breed it with itself, so that again it's an inbred.",
            "And so if you did it just to test, you'd see lots of deviation from the what you predicted.",
            "You know, if the.",
            "Inbred, let's say it's an inbred, and if it's got a A as opposed to BB, but everything else is similar.",
            "You think it's it's it's?",
            "Nothing's been stolen, but you don't know for sure.",
            "And So what we do is we calculate probabilities of ancestry and go back.",
            "You know how far back was this an ancestor and as a result of this Pioneer made hundreds of millions.",
            "Or maybe billions in getting which I received, of course.",
            "Broly"
        ],
        [
            "Over mammography this was science 2010.",
            "A little bit of history back I mentioned this conference."
        ],
        [
            "In 1997 we were presented with all of the available data on the benefits and harms of screening mammography for women in their 40s, and this was our conclusion.",
            "The data currently available do not warrant a universal recommendation for mammography for all women in their 40s, each woman should decide for herself whether to undergo mammography.",
            "What happened after that?",
            "Oh I."
        ],
        [
            "I did an analysis of meta analysis, a Bayesian meta, that's why I'm mentioning it of the trials that were presented in 1997.",
            "In this."
        ],
        [
            "Is a figure from the Journal article from the Journal National Cancer Institute.",
            "Showing.",
            "What they do is they randomize women between getting control.",
            "That is no mammography versus screening.",
            "That is mammography.",
            "There's some contamination in both directions.",
            "The control mortality rate is in the X axis.",
            "Here it's the rate per 100,000 women years, and this is the screening mortality rate.",
            "So if you're above the line, you did better on.",
            "Control and if you're below the law at the 45 degree line, you did better on screening plotted as the difference of percent reduction.",
            "You see quite a bit of variability across here, but if you.",
            "For each one of these, calculate the percent reduction in breast cancer mortality for the screening group you see this spread.",
            "So what I did was do a Bayesian meta analysis and you know it's the usual borrowing strength and got these estimates.",
            "So this C which is Canada, gets shrunk to hear this G which is Gothenburg in Sweden, gets shrunk to here etc.",
            "Something else I put."
        ],
        [
            "In it, which was sort of my undoing was this was the actual plot of the deaths per thousand women overtime, overtime since randomization, and if you integrate between those, you get an estimate of the mean per thousand women, or convert it to women, go out to 15 years.",
            "The life saved per woman.",
            "Was 1.4 days."
        ],
        [
            "And I said, well, there's some more coming here, so let's add in a suit.",
            "Let's extrapolate, and I calculated five days per woman for getting mammography over 10 year.",
            "I was accused of minimizing the benef."
        ],
        [
            "But I said a way to understand the risk is a relate them to other risks and one of the things I said was that.",
            "This was equivalent, getting eschewing mammography in the 40s was equivalent to gaining.",
            "2 ounces of body weight.",
            "And that really was my undoing.",
            "I."
        ],
        [
            "In spite of the evidence and the expert panel, the US Senate.",
            "Voted 98 to 0 dictating that mammography would be effective for women in their 40s and I am not.",
            "That's not a typo.",
            "If you read the resolution, it was essentially telling God, you know that mammography had to be effective.",
            "But more importantly, they withheld the NCIS budget, National Cancer Institute's budget until the NCI agreed to recommend screening for women in their 40s, so naturally they wanted to continue to exist, and so they did."
        ],
        [
            "I'm the Bayes estimates again.",
            "In 2009 these were updated.",
            "Where do you suppose they went?",
            "Notice member Canada was down here.",
            "And we predicted it was was here.",
            "There is the update.",
            "Ostergotland here Gothenberg, which was way up here, so it's an empirical evidence of the shrinkage.",
            "For those astute among you, you may have seen.",
            "That we lost our S innocence.",
            "Supposed to be funny, but.",
            "So we lost our ask where did it go?",
            "It went way off to the side, so this is stokholm and it turned out in stock."
        ],
        [
            "At home there were many more deaths in the control group breast cancer deaths than you could have predicted, so it's like, you know, regression to the mean.",
            "But then there's Wayne Gretzky who doesn't request to.",
            "The main Stockholm didn't regress to the mean.",
            "The 2009 this thing about brawling."
        ],
        [
            "Over mammography Task Force employed modeling.",
            "An randomized control trials to make their recommendation and their recommendation was the same as the recommendation we made 12 years earlier."
        ],
        [
            "This modeling included one Bayesian model.",
            "An MD Anderson model.",
            "And I'll tell you about that.",
            "The reactions to that as."
        ],
        [
            "Of course, recommendation at the Times said the new guidelines draw opposition spark heated debate.",
            "The Globe says breast can egressed screening advice upended and there were lots of charges at the time.",
            "I don't know if you remember death squads, so the charges was.",
            "This was an Obama death squad keeping women from getting these life saving things."
        ],
        [
            "So the models that they used was from sisnett and system that is based on the following."
        ],
        [
            "This is a trends in breast cancer mortality.",
            "Overtime, it's actually here broken out by race, but you see for the whites, which is the biggest group.",
            "The drop is substantial."
        ],
        [
            "Similarly, in UK the drop between 1990 and 2007 was 36%.",
            "So what's causing that?",
            "And the screening people said this is screening mammography, because screening came in in this.",
            "The treatment people said this is treatment.",
            "Because script treatment got very much better, including tamoxifen, including chemotherapy in this same.",
            "So sisnett was a group of seven model is funded by the the NCI to model this process."
        ],
        [
            "And we publish our results and the New England Journal of Medicine and my favorite."
        ],
        [
            "A headline was from CNN.",
            "Statistical blitz helps pin down mammography benefits new."
        ],
        [
            "Times editorial these are some of the data we used.",
            "The everybody opened up their balls of data, the CDC, the NCI, various other groups."
        ],
        [
            "Unfortunately, we don't have in the United States a database like they have in Scandinavian countries where you can follow the same women over time to see what happened.",
            "You know how they were treated or how long they lived.",
            "We had only cross sectional data so we knew who got you know what the proportion of women were that got tamoxifen.",
            "We knew you know what their ages were.",
            "We knew that screened how frequently they get screened etc.",
            "But we didn't know the two things together."
        ],
        [
            "This was a I had to work hard to get my coauthors to understand and to agree to put this in the paper.",
            "This was a.",
            "A kernel estimate estimation for the major things that we were addressing.",
            "This is the reduction in breast cancer mortality due to screening.",
            "This is the reduction due to Agilent treatment and we had the individual models that were spread over the board.",
            "Naturally they were different.",
            "This is model M for MD Anderson.",
            "This is Rochester Erazmus, Wisconsin, Georgetown, Stanford, Dana Farber.",
            "Everyone except Model M was a point estimate.",
            "And I wanted to convey the variability in the modeling by taking this rather gross kernel estimate.",
            "It shows kind of a negative trend, which is sort of expected, because if something is not due to screening, then it's due to something else.",
            "Maybe it's treatment."
        ],
        [
            "I'm so I did the same thing for Model M because Model M is really many models.",
            "We do lots of simulations and if we don't match mortality then we reject it.",
            "If we do then we accept it and we accept the parameters that we use to do the simulation.",
            "So we use using Bayes rule and interesting and not typical way.",
            "You can't simply write down a likelihood function for example."
        ],
        [
            "And so this was ignore the letters for a minute.",
            "These were the models.",
            "This was the same thing I did for our many models that we'd accepted in the.",
            "MD Anderson simulations.",
            "And then I plotted the other models on it and notice that we incorporated all of the models in our uncertainty.",
            "There was some sort of proud of this.",
            "There was."
        ],
        [
            "Norway did a study where they actually tried to separate separate out for their database.",
            "The two things and notice where it went.",
            "Smack on top of the M they they determined about a 10 percent 10% of the drop was due to.",
            "10% of the drop was due to screening 20% of the drop is due to.",
            "Agement therapy"
        ],
        [
            "Conclusions from model M. Bayesian approach ideally suited for comparative effectiveness research.",
            "If you know what that means, or even if you don't know what it means.",
            "The Bayesian approach encompasses the other six models, probability distributions of parameters are necessary for assessing predictive uncertainty."
        ],
        [
            "Now.",
            "I would I dredge this up for the occasion.",
            "To demonstrate to you my knowledge of Japanese."
        ],
        [
            "Seriously, I'm told that this says the coming Bayesian tsunami of clinical development.",
            "And for those of many of you who speak Japanese, if it in fact says pay no attention to this idiot.",
            "Then please don't tell me.",
            "So this is the changing attitude in the medical world generally about the Bayesian approach and looking for something better.",
            "We've achieved this level, the randomized trial, and we sort of complacent in it.",
            "I mean, after all, the randomized trial is over 60 years old, what other innovation do you know has remained essentially unchanged for 60 years?",
            "Think about electronics.",
            "We are complacent with this level and to take it beyond is difficult because they worry that you're going to be throwing out the baby for the bathwater."
        ],
        [
            "Janet Woodcock, who is the director at the time and still is of the Center for Drugs at the FDA, which is very powerful person, was lamenting the sorry straight.",
            "The sorry state of drug development generally and suggested that the improved utilization of adaptive and Bayesian methods could help resolve the low success rate and the expense of phase three clinical trials.",
            "The latest estimate of the cost for developing a drug is 1.8 billion dollars.",
            "And much of that is in phase three, and much of it due to the fact that.",
            "You know many of the drugs fail, and so you have to pay for one with the other."
        ],
        [
            "Current use of Bayesian designs at MD Anderson.",
            "Since I got there in 99, we've had over 300 trials designed and run.",
            "Most of them run.",
            "And the accent on the run.",
            "I mean a lot lot of things that you read in the Bayesian literature is it would be great to do this trial.",
            "But of course nobody's ever done that trial.",
            "We've designed trials that we've actually run device companies.",
            "Many, many designed by Berry consultants that have been over 25 successful approvals of devices taking exclusively a Bayesian approach.",
            "I'll give you one example.",
            "Drug companies, most of the Top 40 companies are taking the Bayesian approach, sometimes in a wholehearted way.",
            "Entire programs are taking a Bayesian approach.",
            "Sometimes it's they just getting their toes in the water so that if this train leaves the station with the force that some people think it's going to leave, they want to be on it."
        ],
        [
            "Some areas of application, essentially every area of application just to contrast on koleji and migraine on koleji.",
            "The endpoints are usually long and coming as you get information.",
            "It takes a long time to get information about what the how the drug was doing.",
            "An individual patient with migraine, the registration endpoint, the endpoint that the FDA uses to make a decision is 2 hours pain free, so it's essentially immediate information."
        ],
        [
            "These are in my sort of rough order of communists, Bayesian adaptive trials stopping early or late.",
            "Sometimes you get to the end of the trial and you wish it weren't over because you don't know the answer, and so you build in the possibility of extending accrual.",
            "Are those finding the example that I mentioned that Peter and I designed for Pfizer and Stroke was dose finding seamless phases where you move from one drug development sort of funny?",
            "At some point you say now I know something.",
            "Like you say, now I know what the dose is.",
            "Just take just thinking like a Bayesian.",
            "You never know anything.",
            "You have a probability distribution and incorporating the information that you have in terms of a probability distribution let's you answer the question you know, do I want to go to an additional?",
            "Do I want to run this additional trial?",
            "What type of trial should I be running in view of the evidence that I have so far?",
            "But the seamless phases where you put the things together you find the dose you morph into a setting where you randomizing to equally, or you identify some other aspect of the drug that you're like how to use it.",
            "Population finding and this is becoming incredibly important in the world of medicine we recognize and cancer, for example, we recognize that were over treating most people.",
            "If you have cancer.",
            "You're more likely to get too much therapy.",
            "We don't know who, so it's to try to identify which subset of patient is benefiting from which therapy, and it is this aspect that is really grabbed ahold of the Bayesian approach and is dragging it into the 21st century.",
            "Adaptive randomization ramping up accrual."
        ],
        [
            "So why do people do this?",
            "Smaller trials, usually more accurate conclusions 'cause you know you you.",
            "It's like driving a car with your eyes open instead of closed.",
            "You're looking at the data, and so you know when you get there, and you know when you want to turn off.",
            "Addresses more questions, so we look at all sorts of questions, how you know how to use the drug.",
            "Is there a subset of the patients that benefit?",
            "It should be used in combination with other drugs, for example.",
            "And maybe better treatment of patients in the trial harkening back to the bandit problem approach where I was explicitly modeling.",
            "You know, treating patients effectively over the course of these hundred coin tosses, and so it's coming.",
            "You know this is a this is a major."
        ],
        [
            "Medical Journal that last week published a paper adaptive.",
            "Clinical trials is a partial remedy for the therapeutic misconception.",
            "Therapeutic misconception is most people in clinical trials think that they're getting their there and they're getting the benefit of experts and are treated effectively.",
            "It ain't so this is to try to.",
            "Make it at least partially so."
        ],
        [
            "So it's related to bandit problems.",
            "This is an example trial that I do."
        ],
        [
            "Signed shortly after I got the MD Anderson.",
            "This is a drug called trucks.",
            "Aside of being in acute myeloid leukemia, the principle principle investigator said I wanted.",
            "Do a trial with 75 patients and I'll put a third of them in each of three arms.",
            "I'll take trucks aside of being and I'll combine it with our one of our two agents that we use Standard Lee in this disease.",
            "Idarubicin and Ara C, So I'll give a third of the patients Idarubicin and Ara.",
            "See the standard.",
            "I'll give a third of the patients idarubicin and truck society being.",
            "I'll give a third of the patients our C and trucks aside to be.",
            "And I said, well, OK, but why don't we look at the data?",
            "An if one of the experimental arms is doing poorly, let's.",
            "Down weight its probability, and if it's doing sufficiently poorly, will shelve it.",
            "And similarly for the other experimental arms.",
            "And if both aren't experimental, arms are doing very poorly.",
            "At the end, we'll just.",
            "We'll just call it."
        ],
        [
            "Calling an end, that is will do adaptive randomization."
        ],
        [
            "So we assign higher probability to better performing therapies.",
            "It turned out in the trial number.",
            "Keep in mind 75 after the 24th patient was treated.",
            "We dropped try to the trucks aside of being idarubicin, THTR, and you'll see why after the 34th patient was treated.",
            "We dropped the other arm and therefore stopped the trial.",
            "So 34 in comparison with 75 and these were the final res."
        ],
        [
            "What's the TI arm?",
            "Had been given to five patients, none of whom achieved a complete remission, which was the end point of the trial and TA it was 27% three out of 11, and in IA it was 56%, which was standard.",
            "I should.",
            "Say it's not quite so neat.",
            "By the way, the PPI submit submitted this paper to the Journal Blood, which is an important Journal in leukemia, and they said you can't learn anything from 5 patients.",
            "And so I said, Frank, why don't you write to him and say if he gets to this disease, we have a treatment for him?",
            "But he didn't do that.",
            "Submit it to the General clinical oncology and they said it's clear that the drug is a dud, but will publish your paper because you you exposed many fewer patients to inferior therapy.",
            "The rest of the story is that the drug company didn't believe this.",
            "And so they managed a phase three trial.",
            "And the phase three trial was closed.",
            "You know, with like 200 patients accrued, you know not nearly what the maximum number was by the data Monitoring Committee because the drug was killing patients.",
            "So they should have listened, but it makes you aware that this is not such an easy question.",
            "What what kind of a randomization should you do?",
            "If we had exposed all 75 patients in the way that Frank originally suggested?",
            "Maybe the company would have been persuaded.",
            "Maybe we would have killed enough people that they would have been persuaded not to run this next trial.",
            "So it's it's a very dicey question.",
            "I don't mean to make it as simple as I perhaps did, but."
        ],
        [
            "But Frank Giles was persuaded.",
            "I see no rationale to further delay moving to these designs, said Doctor Giles, who's currently involved in eight Bayesian based leukemia studies.",
            "They are more ethical.",
            "More patient friendly, more conserving of resources and more statistically desirable."
        ],
        [
            "So, um, Myquest talked about simulations.",
            "Christian talked about simulations.",
            "We do simulations out the wazoo.",
            "You're going to hate this, but one of the things that we do is we calculate type 1 error rate.",
            "So we can't.",
            "We have a very complicated design, but we generate under the null hypothesis to show what the Type 1 error rate is.",
            "And sometimes if this is a registration trial to trial, it's going to go to the FDA.",
            "We have to modify the design.",
            "To get the Type 1 error rate less than point of 025, what that means is.",
            "That we've gone through this Bayesian machinery.",
            "We built this wonderful, clever design.",
            "But then we made it frequentist.",
            "So other things as well."
        ],
        [
            "Two recent can't read that OK, what is it?",
            "15 OK, two recent clinical trials with smaller sample size.",
            "One you they both use Bayesian predicted probabilities actually and they both use Lange tuddal modeling, but just two high profile.",
            "Bayesian trials this one again."
        ],
        [
            "Published in JAMA generally.",
            "American Medical Association, the abstract says."
        ],
        [
            "Respective multicenter randomized 2 to one unblinded Bayesian designed study conducted at 19 hospitals of 167 patients.",
            "So this was about 1/3 less than the maximum the company approached us because accrual was slow and it was going to take forever to for them to finish the trial.",
            "Could we convert it into a Bayesian trial an we did and we did Lange tuddal modeling.",
            "To get early information an we did predicted probabilities such that if we predicted that the answer was going to be clear with additional follow-up, we'd stop the study at that point.",
            "And we did submit it to this.",
            "The Journal and the Journal said.",
            "You did a Bayesian approach.",
            "You have the word Bayesian or abstract.",
            "We don't use the word Bayesian are abstracts.",
            "Now you can imagine.",
            "How livid I was.",
            "And I said, maybe you don't understand.",
            "This trial was designed by a baby from a Bayesian perspective.",
            "The protocol was Bayesian throughout.",
            "It was designed in coordination with the FDA.",
            "It was approved for marketing by the FDA on the basis of an expert panel.",
            "You have an obligation as a medical Journal.",
            "To adhere to the Bible of Medicine, which is the protocol, therefore, you must use the Bayesian approach and the calculations and in the abstract.",
            "Of course I thought I was whistling Dixie.",
            "That's funny.",
            "I thought I was, you know.",
            "But I embarrassed enough so that there it is.",
            "JAMA used the word Bayesian and also the primary analysis are all Bayesian we did.",
            "They did ask us to say, well, what would the analogue in the frequentist B so that we can communicate better to our audience.",
            "So we did have some analogs.",
            "But you know, going in the other direction, taking the data and doing a Bayesian approach.",
            "If the data were collected as a frequentist is easy going in the other direction is not so easy.",
            "Because you don't know what the.",
            "You know what?",
            "The conference, what the actual design of the experiment was.",
            "It wasn't incorporated into the frequentist approach, so we did nominal things."
        ],
        [
            "That I mentioned oncology.",
            "Perhaps the hardest group in oncology to study using an adaptive is.",
            "Early stage breast cancer in elderly women because it tends to be a disease that's innocuous.",
            "In fact, most of it is overdiagnosed patient would never.",
            "Find out that she had the disease.",
            "If you didn't do mammograms sort.",
            "Harken back.",
            "And so the events are not very long and coming.",
            "I mean, I'm very long incoming.",
            "And it took me awhile to build this design because the NCI said you got to do a trial with 2000 patients.",
            "And I said we don't have 2000 patients, will never finish the trial if we have to do 2000 patients."
        ],
        [
            "Was a long time, but I finally had this inspiration that I said, OK, here's what we'll do.",
            "We'll go to 600 patients will do Bayesian predictive calculations.",
            "If with additional follow-up, the probability of having a conclusion.",
            "Yay or nay?",
            "In terms of the.",
            "Objective of the trial will stop accrual will follow the patients for that period of time and then publish the results, and so they finally agreed that we could do that.",
            "And so in clinicaltrials.gov it said, under sample size it said this usually look, it says it's a 2000 patient trial or another one is a 500 patient trial, this one said.",
            "The sample size is 600 to 1800.",
            "Surprise when we looked at six 600.",
            "The Bayesian predictive calculation was such that we were going to have an answer.",
            "We stopped accrual at 600.",
            "Final total was 636 I think.",
            "We followed for the additional 2 years Anne published in.",
            "The New England Journal of positive results.",
            "Or to quote one of my favorite baseball players who was.",
            "Commentating on a baseball game and somebody said something and it had appeared in ESPN, the magazine and he said, well, what do you expect?",
            "That's not the New England Journal of Science?",
            "Joe Morgan, for those of you that know baseball.",
            "I'm."
        ],
        [
            "So these are two of several federal grants that very consultants has and I want to highlight the first one.",
            "Because it couldn't have happened.",
            "20 years ago it couldn't have happened.",
            "10 years ago it probably couldn't have happened five years ago, but Corey is you may have read about.",
            "Obama in a stimulation package.",
            "He assigned 1.1 billion dollars to comparative effectiveness research and that went to establishing this Institute personalized.",
            "This personalized center of outcomes researched Institute.",
            "They sponsor trials.",
            "And some of them they expect are going to be adaptive, so they put out an RFA request for applications and we said will really willing to write your guidance for adaptive designs.",
            "Now mind, you were known as Bayesian adaptive and not as adaptive.",
            "And so we didn't expect we'd get it, but they agreed that we were the authorities on adaptive design generally.",
            "And so we got.",
            "We've actually now written the adaptive design guidance for clinical trials for Cory.",
            "So it's sort of a big deal for Bayesians.",
            "We talk about non Bayesian adaptive designs too.",
            "And we have with a group at the University of Michigan a regulatory science award.",
            "the FDA, NIH, funded four regulatory science grants and one of 'em was with very consultants where we design the trials for this neurology group and using a Bayesian adaptive approach, they run the trials and we address the barriers."
        ],
        [
            "This is."
        ],
        [
            "Roger Lewis talking our current approach to trials is horribly inefficient.",
            "We need to do something better.",
            "Said Roger Lewis, who helps advisor company, called Very Consultants."
        ],
        [
            "Lewis and Berry, along with emergency physician William Barson, the University of Michigan will be studying whether adaptive trial designs that incorporate new information in midcourse can answer medical questions.",
            "They also want to learn what concerns researchers might have about this approach.",
            "So what are the barriers?",
            "What are the problems about doing Bayesian things, for example, and you will not be surprised to know that the biggest barriers we find with statisticians.",
            "So the last thing I want to talk about."
        ],
        [
            "Is this trial called I Spy 2?"
        ],
        [
            "This is Janet Woodcock again writing in the New England Journal of Medicine."
        ],
        [
            "And she advertised I spy two as this groundbreaking trial and breast cancer to predict drug responsiveness based on the presence or absence of genetic and biological markers.",
            "I spy two is a Bayesian trial.",
            "I designed it and it's currently running.",
            "It was advertised in an FDA."
        ],
        [
            "Document here, which I won't go into."
        ],
        [
            "Anne."
        ],
        [
            "Wall Street Journal had a Saturday review essay."
        ],
        [
            "Describing it in here is a. Graph that comes from that."
        ],
        [
            "Article new trial design using genetic profiles to highlight biomarker differences among patients and to match drugs to patients with biomarkers that benefit."
        ],
        [
            "The idea is this is the status quo.",
            "We do small phase two trials, sometimes not even randomized, and then do 3000 patient phase three trials.",
            "Leading to this horrible success rate in phase three, an horribly expensive success rate in phase three.",
            "The idea is to do smaller, more focused trials.",
            "So I dunno if you can identify and Janet Woodcock gets this in spades.",
            "If you can identify the subset of patients.",
            "Who benefit from a drug and not be treating those that don't benefit from the drug?",
            "You can run a much smaller trial.",
            "Which is good for everybody.",
            "It's good for the patients that are being treated in the trial.",
            "It's good for the patients that are not being treated in the trial.",
            "It's good for the patients who come afterwards because you're getting an answer much more quickly.",
            "And finally, it's good for the economy because you're not spending this 1.8 billion dollars.",
            "It's a small, focused, inexpensive, but compelling phase three trial.",
            "And agreed to by the FDA."
        ],
        [
            "So here's a cartoon.",
            "This is the standard approach."
        ],
        [
            "Either you do a single arm trial or you randomize experimental arm and standard and a big deal here is that the population is homogeneous."
        ],
        [
            "The consequences that Onkologie has the worst success rate in phase three.",
            "None are very good, but oncology is the worst one in three trials succeed."
        ],
        [
            "I spy two is a process.",
            "We add arms, subtract arms, we went, but the important thing and we do adaptive randomization.",
            "The important thing is recognizing the population of patients that is heterogeneous.",
            "And we're going to select those patients who are benefiting.",
            "You'll recognize, of course.",
            "That the false positive rate is huge.",
            "So the trial is going to be have to be bigger because we have to beat down those false positives at least to some extent.",
            "Otherwise we'll be making matters worse."
        ],
        [
            "So as we go, perhaps experimental arm two graduates into this small, focused phase three trial, it gets dropped and we continue to adaptively randomize experiment."
        ],
        [
            "ARM 3 is."
        ],
        [
            "Opt for futility."
        ],
        [
            "ARM 5 graduates into a different set and the graduation is based on predictive Bayesian calculations of success in Phase three.",
            "Explicitly looking forward, not only to the rest of the current trial, but also the next trial.",
            "I."
        ],
        [
            "And then we add arms as we go.",
            "We might have."
        ],
        [
            "Example, an adaptively randomized factor."
        ],
        [
            "Oil design is a subset of the arms."
        ],
        [
            "The goal is 85% success rate in phase three with the focus on patients who benefit so."
        ],
        [
            "I like approaches.",
            "We match drugs to biomarker signatures, savings from a common control.",
            "I mean if you in the standard approach, if you're doing these phase two trial, you know our May versus control arm be versus control arm C versus control separate trials.",
            "Even before you do anything clever.",
            "There is an efficiency in having the same control with these various arms.",
            "Better therapies move through faster, get to other patients more quickly.",
            "Successful drug biomarker pairs graduate to a small focus, more successful phase three based on Bayesian predicted probabilities and there's offspring of I spy two and everybody wants to do I spy two colorectal cancer and Melanoma lymphoma.",
            "Alzheimer's disease, HIV, acute heart failure and sorry in H H1N1.",
            "By that I mean the pandemic flu's.",
            "Which is a whole different story of trying to set up a clinical trial because you've got to have it ready.",
            "To go off the block.",
            "The Spanish flu, for example, 1918, was typical in that the peak mortality.",
            "Was two months after we knew the flu is there.",
            "And so you can't wait this time to, you know, develop things.",
            "So we're developing things in advance and the sorry stands for a severe acute respiratory infection.",
            "And we're actually going to be running trials.",
            "International trials in.",
            "Sorry so."
        ],
        [
            "So here is our rough history of Biostatistics revisited.",
            "And here is what?"
        ],
        [
            "Looks like in the 21st century.",
            "Thank you very much.",
            "Questions comments for Don.",
            "Are you are getting ready for the reception so you think of your comments?",
            "Let me quickly swing up there.",
            "Oh sorry.",
            "Said Carrie.",
            "OK, we can hear you, yeah.",
            "So I made a comment that the biggest barriers are in statisticians.",
            "Can I elaborate?",
            "No.",
            "It's very.",
            "It is very difficult for me to elaborate because there individuals involved.",
            "It's it's.",
            "It's a teaching process.",
            "The stuff that we do is not in the repertoire of statisticians.",
            "Generally even Bayesian statisticians, it takes an apprentice ship almost to be able to do these things.",
            "We have some young people in the audience for MD Anderson and you can ask them how they dove into doing clinical trials from a Bayesian perspective, it ain't easy, and it's not something that really anybody learns in their high school.",
            "Ann, I reason I said high school is where my favorite songs is.",
            "Paul Simon's.",
            "Kodachrome when I think back to all the crap I learned in high school, it's a wonder I can think at all.",
            "We don't learn enough in in our education to be able to do these kinds of things, and so there is a bit of I mean.",
            "Imagine telling somebody.",
            "That they're not adaptive.",
            "It's a hard sell, and so we do it gently, but it's it's a represents a barrier.",
            "Sneak in a commercial, there's actually an initiative to start the bio Staten Farmer section in Isba, so maybe that can create momentum and for those of you is the Members and interested to support the new section, please hit is by website and under sections.",
            "There should be a link to support the petition to.",
            "Launched a new section.",
            "Yeah, so can I comment too?",
            "We've had five years of Bayesian Biostatistics at MD Anderson in January, late January, and I've forgotten the dates this year.",
            "But for those of you that are interested in coming and presenting posters, look for our.",
            "Our announcements and come or send me an email and I'll tell you what the circumstances are.",
            "Asian Bio state party.",
            "Press.",
            "Outley Type 1 error.",
            "Simulation Hills there might be many ways that you could adjust the design in order to get a Type 1 error, so could you say a little bit more about how you kind of achieve that?",
            "Is it systematically or by just playing around with these ones?",
            "So the question is, I mentioned type 1 error an we sometimes have to go back to the design and what the case that I mentioned was?",
            "It's a registration trial in order to ensure that we have so called control type one or something I didn't mention was that the FDA has a guidance on adaptive design where their anal about type 1 error.",
            "I mean, essentially every page they say you gotta control type 1 error and their problems.",
            "You know with multiplicity is associated with adaptive design.",
            "So the question is, so how do we do that?",
            "Suppose we build this really interesting clever design.",
            "It looks at lots of questions and the Type 1 error.",
            "The you know the familywise type 1 error is bigger than .025.",
            "Usually there are almost always a variety of things.",
            "Be back up.",
            "There is no single Type 1 error I mentioned.",
            "For example, accrual rate.",
            "If the endpoint is a time to event endpoint, accrual rate is critical.",
            "And if you've got along with so we have to simulate assuming various accrual rates.",
            "And sometimes the accrual rate if the accrual rate is slow, we get bigger than .025.",
            "If it's fast, we get less than .025.",
            "We have to satisfy the FDA in case it's slow.",
            "So there are a variety of things that we can do.",
            "Most typically there's a final cut point or final statistical significance.",
            "You know, or posterior probability that you're claiming in order to have a success, we usually modify that.",
            "And the way we modify it is typically by trial and error.",
            "We can't, we almost none of what we do can be done by analytics.",
            "So we have to do simulation and trial and error is you know as easy as anything.",
            "You are very specific about using Bashan adaptive designs rather than adaptive, So what are the big differences between a bashan adaptive design and adaptive design in terms of results and in terms of what you can do, so Bayesian designs are better?",
            "No, I seriously I yeah.",
            "I mean, I talked about Bayesian adaptive designs because it's what I do.",
            "The adaptive designs more.",
            "If you take a Bayesian perspective, you can say what do I want this trial to do?",
            "What do I want it to be so it has a theme and you can build the trial around that theme?",
            "And typically when I ask?",
            "Clients you know what they want the trial to do.",
            "It's like.",
            "In a Fusion of things that they would like to know the answers to, remember that the standard approach is you ask one question.",
            "An you run the trial and you get the answer to that one question.",
            "They typically have lots of questions so we say keep it coming.",
            "Will address all of these questions, usually in an efficient way does increase the maximum sample size somewhat because we're asking more questions.",
            "So a major difference in this is empirically based between the Bayesian and non Bayesian approach is that the Bayesian approach tends to be more complicated because it addresses more things.",
            "The Bayesian approach tends to be more complicated.",
            "We look much more frequently.",
            "In fact, we run some trials where we're looking everyday at the data and modifying.",
            "You know which way we turn on the basis.",
            "Most non Bayesian approaches are done analytically.",
            "So that they are able to do the calculations.",
            "You know this is multivariate normal that they do.",
            "And integration under some subset whatever.",
            "So most of 'em are done analytically, and that's again, it's an empirical observation.",
            "Probably most of the adapt what is adaptive if you know what a group sequential design is.",
            "It's a design where you do look at it.",
            "In the interim analysis to potentially stop the study in announcing results.",
            "That's adaptive.",
            "It's a pretty simple adaptation, and so we don't.",
            "I don't count that as being adapted when we did this pecori guidance, we described the complex adaptive aspects, not the simple ones of the.",
            "Group sequential if you look at the complex adaptive ones.",
            "Almost all of those are Bayesian.",
            "It's hard to design A complicated study from a frequentist perspective that's looking at lots of questions an you know turning the boat as the wind blows in a different direction.",
            "One more last question for you.",
            "You hear me, yeah, one of the main traits that at least I feel in regulatory interactions that leads to an instinctive, almost opposition to Bayesian methods is a fear of not incorporating or considering sampling variability or things that could have happened but didn't, and I find it really difficult to.",
            "Um?",
            "Let's say discourage this attitude.",
            "If it should be discouraged at all.",
            "Did you find a similar attitude in your regular interactions with FDA?",
            "So, um.",
            "The short answer is no, but with the qualification so nobody's ever accused me of not understanding sampling variability, and in fact I incorporate sampling of variability in the predictive distributions.",
            "You know, in the usual way, there is the sampling variability that we all know and love because we wouldn't have an occupation without it.",
            "But then there is this.",
            "The variability in the parameter, the usual way that people do these things as a condition on.",
            "Parameters we can we don't have to condition on parameters.",
            "We condition on what we know and we don't know the parameters.",
            "But there is a kind of variability that they do worry about.",
            "And that is if you're doing adaptation, let's say adaptive randomization and the patient population changes so that at some point you're looking at the, you know the severe patients, but then you started to look at the less severe patients, so there's variability in the way in which you accrue patients, and for some reason you've given up on one of the arms.",
            "And then you using, you know the rest for the.",
            "There can be biases associated with that.",
            "Usually I mean that we have investigated that buyers.",
            "It's not usually great and usually the using that word too much.",
            "There's covariate information that you can take into account so that you can correlate what is happening to the patient overtime that you're seeing different patient populations as measured by aggressiveness of disease or stage of disease or something.",
            "So I'm not sure what you meant by sampling variability.",
            "But it looks like I answered your question.",
            "Or it looks like you want to go out and get some wine or something.",
            "Thank you.",
            "That's right bus, but so let's thank Don again, thank you."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Next is my lecture, which should really be titled slowly but surely danbarry revolutionizes medical research.",
                    "label": 1
                },
                {
                    "sent": "It's a real privilege to introduce the speaker for our next lecture.",
                    "label": 0
                },
                {
                    "sent": "Danbarry over the last 1520 years and more.",
                    "label": 0
                },
                {
                    "sent": "Has been relentlessly working on introducing.",
                    "label": 0
                },
                {
                    "sent": "Innovative, coherent, wonderful vision ideas.",
                    "label": 0
                },
                {
                    "sent": "An the research and planning for clinical studies and has made a lot of difference in doing so.",
                    "label": 0
                },
                {
                    "sent": "And will tell us some of the exciting success stories now please thank you, Peter, and thanks to the organizers.",
                    "label": 0
                },
                {
                    "sent": "It's been a bit more than 15 years.",
                    "label": 0
                },
                {
                    "sent": "So I'm going to talk about mainly about designing experiments from a Bayesian perspective.",
                    "label": 0
                },
                {
                    "sent": "When is, but was formed.",
                    "label": 0
                },
                {
                    "sent": "I argued to the powers that were that the Bayesian approach was more important.",
                    "label": 0
                },
                {
                    "sent": "In designing experiments then and analyzing them, I tried to get them to incorporate the word design in addition to analysis.",
                    "label": 0
                },
                {
                    "sent": "So for example, the International Society of Bayesian analysis and design.",
                    "label": 0
                },
                {
                    "sent": "But the acronym didn't work, so we're left without the design, but you'll get some today.",
                    "label": 0
                },
                {
                    "sent": "So this is a rough year.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Tree Biostatistics, very rough.",
                    "label": 0
                },
                {
                    "sent": "In the 1800s, in the early 1900s, there was a continual tug between those who said.",
                    "label": 0
                },
                {
                    "sent": "You should.",
                    "label": 0
                },
                {
                    "sent": "You should pay attention to the data you treat a patient and you gotta take take into consideration what happens to that patient and put together lots of patients and to draw a conclusion as to whether the treatment is effective.",
                    "label": 0
                },
                {
                    "sent": "Against the attitude among physicians that this is my patient, my patient is unique.",
                    "label": 0
                },
                {
                    "sent": "I know my patient.",
                    "label": 0
                },
                {
                    "sent": "And you can't tell me how to treat my patient.",
                    "label": 0
                },
                {
                    "sent": "That attitude I talked about it as being nineteen, 1800s and 1900s persists today.",
                    "label": 0
                },
                {
                    "sent": "I I was testifying to Congress to a Senate committee Bill Frist, who at the time was the Senate Majority Leader was on the panel and asking me his five minutes to ask me questions and he spent his five minutes telling me and everybody else that he was an MD.",
                    "label": 0
                },
                {
                    "sent": "And I wasn't.",
                    "label": 0
                },
                {
                    "sent": "I notice the WR, Thompson and Bays in 1933.",
                    "label": 0
                },
                {
                    "sent": "In a series of papers, he laid out a Bayesian approach to clinical trials.",
                    "label": 0
                },
                {
                    "sent": "And it was really quite neat.",
                    "label": 0
                },
                {
                    "sent": "It was very interesting because in his 1933 biometrika paper, the first page.",
                    "label": 0
                },
                {
                    "sent": "Said everything that anybody was interested in, and the next 10 pages talked about how you could compute incomplete beta functions.",
                    "label": 0
                },
                {
                    "sent": "Of course, today it's just you plug into the computer, sometimes doing simulations to get the answer, but the core was in at 1st and I'll talk a little bit about that.",
                    "label": 0
                },
                {
                    "sent": "In 1997, the frequentist half century that's critical, so in the 1940s Bradford Bradford Hill discovered, founded, put forth the notion of randomization course.",
                    "label": 1
                },
                {
                    "sent": "Randomization goes back to least Fisher in the context of agricultural experiments and Bradford Hill in the 1940s suggested it in clinical trials.",
                    "label": 0
                },
                {
                    "sent": "And is widely regarded as being the father of randomized clinical trials.",
                    "label": 0
                },
                {
                    "sent": "That established the level of evidence that we are that the medical profession continues to be in reference of an the.",
                    "label": 0
                },
                {
                    "sent": "Second half of the 19th of the 18th.",
                    "label": 0
                },
                {
                    "sent": "I'll get it right.",
                    "label": 0
                },
                {
                    "sent": "The 20th century was what I called a frequentist half century, essentially knowbase.",
                    "label": 0
                },
                {
                    "sent": "There were a few people crying in the wilderness like me.",
                    "label": 0
                },
                {
                    "sent": "I it during this.",
                    "label": 0
                },
                {
                    "sent": "I was on the train in Washington DC and somebody from the FDA came up to me and said, you know, Don, I've, I've heard you talk about Bayes approaches many times and every time I hear you, I become a Bayesian.",
                    "label": 0
                },
                {
                    "sent": "For 10 minutes.",
                    "label": 0
                },
                {
                    "sent": "So ever since then, I've been working on a sustained relief version.",
                    "label": 0
                },
                {
                    "sent": "His sustained, released version.",
                    "label": 0
                },
                {
                    "sent": "So now.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "1897 There was a Turning point Congress in the United States was pushing the FDA, too.",
                    "label": 0
                },
                {
                    "sent": "Take it easy on medical device companies asking them to do these huge trials didn't make sense and there were there.",
                    "label": 0
                },
                {
                    "sent": "There's something like 30,000 medical device companies in the world and there is about 1000 or less pharmaceutical companies and pharmaceutical and getting smaller all the time as they gobble each other up.",
                    "label": 0
                },
                {
                    "sent": "And the medical device companies sometimes don't have statisticians frequently don't they?",
                    "label": 0
                },
                {
                    "sent": "Don't.",
                    "label": 0
                },
                {
                    "sent": "They can't afford to run clinical trials.",
                    "label": 0
                },
                {
                    "sent": "So Congress passed the so-called fadama.",
                    "label": 0
                },
                {
                    "sent": "the FDA Modernization Act, and they used the term least burdensome, and that term was taken by the FDA as be Bayesian.",
                    "label": 0
                },
                {
                    "sent": "And since then I'll tell you about some of the rest of that story, so this is.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "To be personal and I'll tell you about my exposures overtime to the medical world and how I've tried to impact the way people think about things in 1970 in my dissertation I talked about bandit problems, design of an experiment.",
                    "label": 1
                },
                {
                    "sent": "Yeah, you probably don't know what they are, so let me let me give you a very simple example.",
                    "label": 0
                },
                {
                    "sent": "You have two coins.",
                    "label": 0
                },
                {
                    "sent": "You don't know the probabilities of heads on either coin.",
                    "label": 0
                },
                {
                    "sent": "I tell you that you can toss a coin.",
                    "label": 0
                },
                {
                    "sent": "Every time between the two, every time you get heads, I'll give you a dollar.",
                    "label": 0
                },
                {
                    "sent": "Every time you get tails you get nothing.",
                    "label": 0
                },
                {
                    "sent": "And I'll give you 100 tosses so you can make a maximum of $100.",
                    "label": 0
                },
                {
                    "sent": "Or yen, although I guess he'd rather make $100.",
                    "label": 0
                },
                {
                    "sent": "And you get to look at the results.",
                    "label": 0
                },
                {
                    "sent": "So you take a coin, you toss it, you get heads.",
                    "label": 0
                },
                {
                    "sent": "You want a dollar, but you also get information that this coin is pretty good.",
                    "label": 0
                },
                {
                    "sent": "You might say, well, I'll use it again.",
                    "label": 0
                },
                {
                    "sent": "You use it again and you get heads.",
                    "label": 0
                },
                {
                    "sent": "It's looking even better, so driven you use it again, you get tails.",
                    "label": 0
                },
                {
                    "sent": "Now it's not looking too bad.",
                    "label": 0
                },
                {
                    "sent": "You know two out of three ain't bad.",
                    "label": 0
                },
                {
                    "sent": "Who is it was a song, two or three?",
                    "label": 0
                },
                {
                    "sent": "But there's this other coin that's sitting there untried.",
                    "label": 0
                },
                {
                    "sent": "And maybe it's better.",
                    "label": 0
                },
                {
                    "sent": "Which one is the optimal one to use?",
                    "label": 0
                },
                {
                    "sent": "Is it the first one or the second one?",
                    "label": 0
                },
                {
                    "sent": "You have 97 more tosses to go.",
                    "label": 0
                },
                {
                    "sent": "I claim it's not an easy problem and where's my quest?",
                    "label": 0
                },
                {
                    "sent": "The solution is by dynamic programming or backward induction.",
                    "label": 0
                },
                {
                    "sent": "Depends on the prior distribution that you had.",
                    "label": 0
                },
                {
                    "sent": "If, for example, I'll just tell you the answer.",
                    "label": 0
                },
                {
                    "sent": "If there are uniform on both independent uniform on both, the answer is you use the one that gave two out of three.",
                    "label": 0
                },
                {
                    "sent": "But if you lose the next time, you definitely want to switch.",
                    "label": 0
                },
                {
                    "sent": "1980 is something I have to tell you about myself.",
                    "label": 0
                },
                {
                    "sent": "I have six kids and I was on the faculty of the University of Minnesota and they were making even less money than they are today, which is not much.",
                    "label": 0
                },
                {
                    "sent": "And so I started consulting for what is now 3M Laboratories and I sort of learned the hard way.",
                    "label": 0
                },
                {
                    "sent": "But what medical research was about?",
                    "label": 0
                },
                {
                    "sent": "I thought that this you know, bandit problems, that's the way they run.",
                    "label": 0
                },
                {
                    "sent": "Clinical trials you learn as you go and you try to treat patients effectively with time.",
                    "label": 0
                },
                {
                    "sent": "I reminded Peter and I, Peter Mueller, and I designed a trial for Pfizer about 15 years ago.",
                    "label": 0
                },
                {
                    "sent": "Stroke it was Bayesian through and through.",
                    "label": 0
                },
                {
                    "sent": "We worked hard at it, designed a great trial.",
                    "label": 0
                },
                {
                    "sent": "When I attracted Peter to come to MD Anderson.",
                    "label": 0
                },
                {
                    "sent": "He started to see the way other trials were designed and he said, you know, Don.",
                    "label": 0
                },
                {
                    "sent": "I thought every trial was like the trial we designed for Pfizer and I'm learning that they are pretty dumb.",
                    "label": 0
                },
                {
                    "sent": "So my reaction was the same when I went to Duke I was asked to participate in something called a CLG beta cancer and leukemia Group B, which is a national oncology group.",
                    "label": 1
                },
                {
                    "sent": "Anne was assigned breast cancer.",
                    "label": 0
                },
                {
                    "sent": "High in the 1980s I helped in 1990s I helped the FDA with their Bayesian Initiative 1997.",
                    "label": 0
                },
                {
                    "sent": "I happened to serve on a consensus development conference with the NIH National Institutes of Health on Screening Mammography for women in their 40s.",
                    "label": 1
                },
                {
                    "sent": "I was Co chair of the panel, and I'll tell you a little bit about that.",
                    "label": 0
                },
                {
                    "sent": "1999 went to MD Anderson.",
                    "label": 0
                },
                {
                    "sent": "And we've designed lots of trials from a Bayesian perspective, and I'll mention that as well.",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "In 2015 were coming around, and so it's you know it's it's the hitting the circuit here and I think we're coming back to bandit problems.",
                    "label": 0
                },
                {
                    "sent": "By the way, I should say that it isn't only in medicine.",
                    "label": 0
                },
                {
                    "sent": "I don't know if Steve Scott is at this.",
                    "label": 0
                },
                {
                    "sent": "Conference, but Steve works at Google and they are heavily into bandit problems.",
                    "label": 0
                },
                {
                    "sent": "You know, when you Google something.",
                    "label": 0
                },
                {
                    "sent": "There are some advertisements on the side.",
                    "label": 0
                },
                {
                    "sent": "Every time you click an ad.",
                    "label": 0
                },
                {
                    "sent": "Google makes money.",
                    "label": 0
                },
                {
                    "sent": "What they want you to do is to click the ad and there are ways there are various kinds of ads that they can put on the thing to attract you.",
                    "label": 0
                },
                {
                    "sent": "You know they can put a blue background with, say, three watch is or a single watch that looks like a Rolex.",
                    "label": 0
                },
                {
                    "sent": "Or they're selling watches or a woman with low cleavage wearing a watch or not.",
                    "label": 0
                },
                {
                    "sent": "They want you to hit, but they can experiment.",
                    "label": 0
                },
                {
                    "sent": "And they know when you're looking at it and you don't hit, so they know the denominator.",
                    "label": 0
                },
                {
                    "sent": "How should they configure so as to maximize their profit over the long term?",
                    "label": 0
                },
                {
                    "sent": "It's a bandit problem, it's a multi armed bandit problem where they've got all kinds of possibilities for configuring the ad.",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Five top three reasons for Bayes.",
                    "label": 1
                },
                {
                    "sent": "And one of the things you don't see here in the Bio Statistical area is subjective probability and measures that use the data in an appropriate way.",
                    "label": 0
                },
                {
                    "sent": "That sort of implicit in some of these, but online learning.",
                    "label": 0
                },
                {
                    "sent": "So you see it, you see something and you take advantage of it, something that hasn't been done heretofore in Biostatistics predicted probabilities.",
                    "label": 0
                },
                {
                    "sent": "So we when we design trials.",
                    "label": 0
                },
                {
                    "sent": "Very consultants.",
                    "label": 0
                },
                {
                    "sent": "When we design trials we use we everything is predictive.",
                    "label": 0
                },
                {
                    "sent": "Where are we going?",
                    "label": 0
                },
                {
                    "sent": "And do we want to go there?",
                    "label": 0
                },
                {
                    "sent": "Or do we want to change the trial design?",
                    "label": 0
                },
                {
                    "sent": "Not that we you know, this is all done prospectively, or do we want to change and go in a different direction?",
                    "label": 0
                },
                {
                    "sent": "Again, every direction is prospectively described modeling hierarchical modeling.",
                    "label": 0
                },
                {
                    "sent": "Modeling quite generally and decision and.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "This is so somebody, but I asked about genetic, so several examples in genetics.",
                    "label": 0
                },
                {
                    "sent": "In paternity testing, which is down near the bottom here.",
                    "label": 0
                },
                {
                    "sent": "I testify when when I was in Minnesota in a number of cases of paternity suits.",
                    "label": 0
                },
                {
                    "sent": "And the way they did the calculations, you know they had like say 10 genes an in father mother and child and they would multiply everything together, which is not necessarily right, but they come up with a number which is essentially a likelihood ratio, and then they would say this is the likely they would convert that into a probability, and that this is the likelihood of paternity.",
                    "label": 0
                },
                {
                    "sent": "Or after I complained about it.",
                    "label": 0
                },
                {
                    "sent": "The Blood bank started to use the plausibility of paternity.",
                    "label": 0
                },
                {
                    "sent": "What it was was the posterior probability of paternity.",
                    "label": 0
                },
                {
                    "sent": "Assuming that every man had a 50% chance of being the father.",
                    "label": 0
                },
                {
                    "sent": "So they just converted the likelihood ratio into into an odds ratio and it didn't matter that they had three men, all of whom had, you know, 50% or more.",
                    "label": 0
                },
                {
                    "sent": "And that led to the ancestry for.",
                    "label": 0
                },
                {
                    "sent": "Corn, soybeans cattle Cabernet Sauvignon the model that I built that I'll tell you a little bit about was used to show that Cabernet Sauvignon.",
                    "label": 1
                },
                {
                    "sent": "Is in fact a descendant of centuries old descendant of Cabernet Franc and Sauvignon Blanc.",
                    "label": 0
                },
                {
                    "sent": "DNA fingerprinting, BRCA pro doping.",
                    "label": 0
                },
                {
                    "sent": "I'll tell you about these.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So this is a.",
                    "label": 0
                },
                {
                    "sent": "A series of papers that I wrote with Ian Evatt and the UK at the time, the Home Office Forensic Science Service where we did Bayesian things an we incorporated.",
                    "label": 0
                },
                {
                    "sent": "And and what they did was they in the DNA profiling.",
                    "label": 0
                },
                {
                    "sent": "They looked at fragment lengths and they would multiply the probabilities associated with the fragment lengths.",
                    "label": 0
                },
                {
                    "sent": "Assuming independence, which was absolutely not true.",
                    "label": 0
                },
                {
                    "sent": "So what this thing does is reckons with the correlations among the data.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "When I was at Duke Giovanni Parmigiani and I, along with others at Iverson, Omar Aguilar built a model that's still used today.",
                    "label": 0
                },
                {
                    "sent": "In fact, it's the most commonly used model for assessing the probability of carrier status of that somebody carries a mutation of BRCA, one breast cancer gene or BRCA two based on family history.",
                    "label": 0
                },
                {
                    "sent": "Of.",
                    "label": 0
                },
                {
                    "sent": "Breast cancer, ovarian cancer, and some other cancers.",
                    "label": 0
                },
                {
                    "sent": "And this is a paper.",
                    "label": 0
                },
                {
                    "sent": "This was a validation of it that concluded BRCA Pro marries Mendel and Bayes.",
                    "label": 0
                },
                {
                    "sent": "It uses the hereditary characteristics and incorporates the Bayesian modeling of various steps in the probability line.",
                    "label": 0
                },
                {
                    "sent": "You can do it analytically if the family is small, but you have to do something like simulation of the family is larger if you're considering lots of.",
                    "label": 0
                },
                {
                    "sent": "Different kinds of cancers, different ages, which patients have had cancers or not, and we.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Included in this one paper or BRCA pros.",
                    "label": 0
                },
                {
                    "sent": "Accurate genetic testing for BRCA one and BRCA two is highly sensitive.",
                    "label": 1
                },
                {
                    "sent": "Missing an estimated 15% of mutations.",
                    "label": 1
                },
                {
                    "sent": "I've been telling people at Duke and otherwise that stop looking for BRCA 3.",
                    "label": 0
                },
                {
                    "sent": "It doesn't exist if it exists.",
                    "label": 0
                },
                {
                    "sent": "There's only a small penetrance.",
                    "label": 0
                },
                {
                    "sent": "There's only a small proportion of the patients who have it, or it elevates the risk of breast cancer only slightly.",
                    "label": 0
                },
                {
                    "sent": "And so this is 15 years ago.",
                    "label": 0
                },
                {
                    "sent": "And I couldn't convince people and they continue to look for BRCA three and the update for you today.",
                    "label": 0
                },
                {
                    "sent": "Is that nobody is yet found the BRCA 3.",
                    "label": 0
                },
                {
                    "sent": "These were the data that I based that on.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So this is the BRCA pro probability.",
                    "label": 0
                },
                {
                    "sent": "With you know sets of people 60 in each group.",
                    "label": 0
                },
                {
                    "sent": "Then look to see how many were actually positive.",
                    "label": 0
                },
                {
                    "sent": "This is predicting whether you carrying this mutation and down in the lower reaches.",
                    "label": 0
                },
                {
                    "sent": "We were underestimating and in the higher reaches we were overestimating.",
                    "label": 0
                },
                {
                    "sent": "It's improved since this was over 10 years ago.",
                    "label": 0
                },
                {
                    "sent": "But you'll notice that up here we are uniformly.",
                    "label": 0
                },
                {
                    "sent": "Undershooting and so there is.",
                    "label": 0
                },
                {
                    "sent": "There's something there that we're missing could be more mutations on the same gene.",
                    "label": 0
                },
                {
                    "sent": "It could be other jeans and so, but it's not much, and that was the point.",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "In five years ago or so I wrote this paper for nature commentary called the Science of doping, or lack thereof.",
                    "label": 0
                },
                {
                    "sent": "Pictures of Floyd Landis in the 2006 Tour de France.",
                    "label": 0
                },
                {
                    "sent": "And.",
                    "label": 0
                },
                {
                    "sent": "I complained about the science at the World Anti Doping Agency water saying that it essentially didn't exist.",
                    "label": 0
                },
                {
                    "sent": "And things haven't changed.",
                    "label": 0
                },
                {
                    "sent": "Just last week I was in Lausanne, Switzerland.",
                    "label": 0
                },
                {
                    "sent": "A scientific council for a case involving human growth hormone.",
                    "label": 0
                },
                {
                    "sent": "And you probably read about this sort of stuff back with Floyd Landis.",
                    "label": 0
                },
                {
                    "sent": "And in those days it was testosterone.",
                    "label": 0
                },
                {
                    "sent": "The doping dujour is human growth hormone.",
                    "label": 0
                },
                {
                    "sent": "And water has a test for it.",
                    "label": 0
                },
                {
                    "sent": "Tell you about one example of a statistical calculation that they make.",
                    "label": 0
                },
                {
                    "sent": "Here's what they do.",
                    "label": 0
                },
                {
                    "sent": "They look at what individuals cases that they run in the course of the various events they look at, what their growth hormone was.",
                    "label": 0
                },
                {
                    "sent": "So you can imagine that there is a big clump of values of the growth hormone, and then there's a smattering of higher values.",
                    "label": 0
                },
                {
                    "sent": "So here's what they do.",
                    "label": 0
                },
                {
                    "sent": "They say those higher values must be users.",
                    "label": 0
                },
                {
                    "sent": "The ones in the middle are not users.",
                    "label": 0
                },
                {
                    "sent": "So they said we're going to take those and go to fit a distribution.",
                    "label": 0
                },
                {
                    "sent": "And the distribution, it looks like it fits best is the lognormal.",
                    "label": 0
                },
                {
                    "sent": "And then they take the 99.99 percentile of the lognormal and call that the cut point, and they say we have a one in 10,000.",
                    "label": 0
                },
                {
                    "sent": "Chance of a false positive.",
                    "label": 0
                },
                {
                    "sent": "You see 99.991 minus.",
                    "label": 0
                },
                {
                    "sent": "The rub is.",
                    "label": 0
                },
                {
                    "sent": "That the data that they had for normals totaled 140 cases.",
                    "label": 0
                },
                {
                    "sent": "None of which was bigger than the cut point because they had cut the tail of the distribution.",
                    "label": 0
                },
                {
                    "sent": "So here's what they did.",
                    "label": 0
                },
                {
                    "sent": "If in effect they cut off the tail.",
                    "label": 0
                },
                {
                    "sent": "And then said look, it has a small tail.",
                    "label": 0
                },
                {
                    "sent": "Anyway, the science is abysmal, and that's just one example.",
                    "label": 0
                },
                {
                    "sent": "Are a point of oh, I should have critical issue here.",
                    "label": 0
                },
                {
                    "sent": "This was the penultimate version at the 11th hour.",
                    "label": 0
                },
                {
                    "sent": "Nature.",
                    "label": 0
                },
                {
                    "sent": "Got spooked by the possibility that was real, actually, that WADA would Sue them for publishing this article, and so right at the.",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "11th hour they took our lack thereof off.",
                    "label": 0
                },
                {
                    "sent": "One of the things I talk about in the.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Articles of prosecutors fallacy.",
                    "label": 0
                },
                {
                    "sent": "The here's what they do.",
                    "label": 0
                },
                {
                    "sent": "They conclude that if you have a very small chance of something.",
                    "label": 0
                },
                {
                    "sent": "That you must be guilty with probability 1 minus that.",
                    "label": 0
                },
                {
                    "sent": "So they are mixing up, you know they're inverting the conditional, and I explained that this you have to use Bayes rule to do that.",
                    "label": 0
                },
                {
                    "sent": "If you want to read more about the prosecutors fallacy, Google, Mark Buchanan the prosecutors fallacy.",
                    "label": 1
                },
                {
                    "sent": "It'll take you to a New York Times article by Buchanan about a woman named on the Burke from the Netherlands who had the misfortune of being in the operating room when lots of patients died.",
                    "label": 0
                },
                {
                    "sent": "She was tried.",
                    "label": 0
                },
                {
                    "sent": "On the basis of the rarity of the confluence of all of those things, and a very small probability that this was going to happen, and therefore she was guilty.",
                    "label": 0
                },
                {
                    "sent": "When I wrote this article, I cited Buchanan.",
                    "label": 0
                },
                {
                    "sent": "And the editor said no, I want to take that off.",
                    "label": 0
                },
                {
                    "sent": "I said why?",
                    "label": 0
                },
                {
                    "sent": "It's an elegant paper.",
                    "label": 0
                },
                {
                    "sent": "He said that's the problem.",
                    "label": 0
                },
                {
                    "sent": "He writes better than you do.",
                    "label": 0
                },
                {
                    "sent": "If you want to see something another elegant presentation, Google Peter Donnelly in the Ted Conference and he'll tell you about a similar case.",
                    "label": 0
                },
                {
                    "sent": "Sally Clark in UK that was convicted of killing two of her kids who died of SIDS.",
                    "label": 0
                },
                {
                    "sent": "Sudden, sudden infant death syndrome in UK they called Crib Death.",
                    "label": 0
                },
                {
                    "sent": "And this doesn't happen.",
                    "label": 0
                },
                {
                    "sent": "Very often and they calculated a probability of one in 70 some million that it happens and therefore she's guilty.",
                    "label": 0
                },
                {
                    "sent": "Now mind you, here's an instance where we don't even know there was a crime, just like with on a divert.",
                    "label": 0
                },
                {
                    "sent": "Anyway, Donnelly does a terrific job explaining this and it in telling you how a pediatrician is doing statistics and would you go over a bridge if you knew that this pediatrician had built the bridge?",
                    "label": 0
                },
                {
                    "sent": "Is it anyway?",
                    "label": 0
                },
                {
                    "sent": "Anish.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Issue that's very difficult to describe.",
                    "label": 0
                },
                {
                    "sent": "To get people to understand in the 2006 Tour de France because Landis wrote one several of the heats and was the leader obviously was the winner.",
                    "label": 0
                },
                {
                    "sent": "At the end he had more tests than anybody else.",
                    "label": 0
                },
                {
                    "sent": "He had eight of the 126 Tests that had been done.",
                    "label": 0
                },
                {
                    "sent": "So it's multiplicity.",
                    "label": 0
                },
                {
                    "sent": "You know if you do things enough, you'll see unusual things and incorporate according incorporating that into the analysis is something that can and should be done.",
                    "label": 0
                },
                {
                    "sent": "I.",
                    "label": 0
                },
                {
                    "sent": "You know this is strategy like issues of strategy.",
                    "label": 0
                },
                {
                    "sent": "Suppose you're a bicyclist.",
                    "label": 0
                },
                {
                    "sent": "And suppose you know the law is correct that lots of these bicyclists are using dope.",
                    "label": 0
                },
                {
                    "sent": "You know that if someone so gets tested these times, he's probably going to be illuminated.",
                    "label": 0
                },
                {
                    "sent": "And so you, because you're, you know, mediocre bicyclists aren't going to be tested at all.",
                    "label": 0
                },
                {
                    "sent": "And so you know, if you lay back.",
                    "label": 0
                },
                {
                    "sent": "Maybe the people that come in ahead of you will all be eliminated and you win.",
                    "label": 0
                },
                {
                    "sent": "It's not a fair policy, it's hard to complain about in any particular instance, but it's not fair, but it's absolutely standard.",
                    "label": 0
                },
                {
                    "sent": "If you're good, you get tested a lot.",
                    "label": 0
                },
                {
                    "sent": "This was.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "An example Gan genetics.",
                    "label": 0
                },
                {
                    "sent": "It was a consulting project for pioneer seeds, which is now part of DuPont where they had cases where their germplasm was being stolen, so they make they have corn seeds for example they sell to farmers.",
                    "label": 0
                },
                {
                    "sent": "Farmers put it in the ground and it grows what they sell or hybrids.",
                    "label": 0
                },
                {
                    "sent": "These are things that are bred in such a way that it's very uniform.",
                    "label": 0
                },
                {
                    "sent": "So when you look at the the rows of corn, they're all the same height.",
                    "label": 0
                },
                {
                    "sent": "And people have been stealing their germplasm in several ways.",
                    "label": 0
                },
                {
                    "sent": "The cutest way is the way.",
                    "label": 0
                },
                {
                    "sent": "The corn is bread.",
                    "label": 0
                },
                {
                    "sent": "The way it sits.",
                    "label": 0
                },
                {
                    "sent": "The corn seeds are our bread for putting in the bags, and the farmer buys is you take 2 inbreds.",
                    "label": 0
                },
                {
                    "sent": "The hybrid is a cross between two inbreds.",
                    "label": 0
                },
                {
                    "sent": "The inbreds are essentially all homozygous.",
                    "label": 0
                },
                {
                    "sent": "So whenever you put to him together you get the same thing.",
                    "label": 0
                },
                {
                    "sent": "And the way they grow these things is they they don't want the the self germination.",
                    "label": 0
                },
                {
                    "sent": "So they hire high school kids for example, to go through the fields and everybody who is, you know the one inbred.",
                    "label": 0
                },
                {
                    "sent": "The female inbred you pull the tusks off so it can't breed itself.",
                    "label": 0
                },
                {
                    "sent": "Kasian Lee they miss and so occasionally the inbred breeds itself an this Colonel in the bag of corn.",
                    "label": 0
                },
                {
                    "sent": "Comes from that matching.",
                    "label": 0
                },
                {
                    "sent": "So what the competitors do and this is against the law is they.",
                    "label": 0
                },
                {
                    "sent": "There's a bag tag rule is they buy bags of pioneer seeds and they plan.",
                    "label": 0
                },
                {
                    "sent": "And almost all of the corn is uniformly high.",
                    "label": 0
                },
                {
                    "sent": "Maybe all of it is uniformly, but occasionally there's this runt.",
                    "label": 0
                },
                {
                    "sent": "The runt is the inbred.",
                    "label": 0
                },
                {
                    "sent": "It's the, it's the Crown jewels and so they take that one now.",
                    "label": 0
                },
                {
                    "sent": "If they use that and they did genetic analysis, it would be clear that they had stolen it.",
                    "label": 0
                },
                {
                    "sent": "So what they do is they take it and they made it with some other similar inbred to get you know genetic variation variation and then they self it out.",
                    "label": 0
                },
                {
                    "sent": "They essentially breed it with itself, so that again it's an inbred.",
                    "label": 0
                },
                {
                    "sent": "And so if you did it just to test, you'd see lots of deviation from the what you predicted.",
                    "label": 0
                },
                {
                    "sent": "You know, if the.",
                    "label": 0
                },
                {
                    "sent": "Inbred, let's say it's an inbred, and if it's got a A as opposed to BB, but everything else is similar.",
                    "label": 0
                },
                {
                    "sent": "You think it's it's it's?",
                    "label": 0
                },
                {
                    "sent": "Nothing's been stolen, but you don't know for sure.",
                    "label": 0
                },
                {
                    "sent": "And So what we do is we calculate probabilities of ancestry and go back.",
                    "label": 0
                },
                {
                    "sent": "You know how far back was this an ancestor and as a result of this Pioneer made hundreds of millions.",
                    "label": 0
                },
                {
                    "sent": "Or maybe billions in getting which I received, of course.",
                    "label": 0
                },
                {
                    "sent": "Broly",
                    "label": 0
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Over mammography this was science 2010.",
                    "label": 0
                },
                {
                    "sent": "A little bit of history back I mentioned this conference.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "In 1997 we were presented with all of the available data on the benefits and harms of screening mammography for women in their 40s, and this was our conclusion.",
                    "label": 0
                },
                {
                    "sent": "The data currently available do not warrant a universal recommendation for mammography for all women in their 40s, each woman should decide for herself whether to undergo mammography.",
                    "label": 1
                },
                {
                    "sent": "What happened after that?",
                    "label": 0
                },
                {
                    "sent": "Oh I.",
                    "label": 0
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I did an analysis of meta analysis, a Bayesian meta, that's why I'm mentioning it of the trials that were presented in 1997.",
                    "label": 0
                },
                {
                    "sent": "In this.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Is a figure from the Journal article from the Journal National Cancer Institute.",
                    "label": 0
                },
                {
                    "sent": "Showing.",
                    "label": 0
                },
                {
                    "sent": "What they do is they randomize women between getting control.",
                    "label": 0
                },
                {
                    "sent": "That is no mammography versus screening.",
                    "label": 0
                },
                {
                    "sent": "That is mammography.",
                    "label": 0
                },
                {
                    "sent": "There's some contamination in both directions.",
                    "label": 0
                },
                {
                    "sent": "The control mortality rate is in the X axis.",
                    "label": 0
                },
                {
                    "sent": "Here it's the rate per 100,000 women years, and this is the screening mortality rate.",
                    "label": 0
                },
                {
                    "sent": "So if you're above the line, you did better on.",
                    "label": 0
                },
                {
                    "sent": "Control and if you're below the law at the 45 degree line, you did better on screening plotted as the difference of percent reduction.",
                    "label": 0
                },
                {
                    "sent": "You see quite a bit of variability across here, but if you.",
                    "label": 0
                },
                {
                    "sent": "For each one of these, calculate the percent reduction in breast cancer mortality for the screening group you see this spread.",
                    "label": 0
                },
                {
                    "sent": "So what I did was do a Bayesian meta analysis and you know it's the usual borrowing strength and got these estimates.",
                    "label": 0
                },
                {
                    "sent": "So this C which is Canada, gets shrunk to hear this G which is Gothenburg in Sweden, gets shrunk to here etc.",
                    "label": 0
                },
                {
                    "sent": "Something else I put.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "In it, which was sort of my undoing was this was the actual plot of the deaths per thousand women overtime, overtime since randomization, and if you integrate between those, you get an estimate of the mean per thousand women, or convert it to women, go out to 15 years.",
                    "label": 0
                },
                {
                    "sent": "The life saved per woman.",
                    "label": 1
                },
                {
                    "sent": "Was 1.4 days.",
                    "label": 0
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And I said, well, there's some more coming here, so let's add in a suit.",
                    "label": 0
                },
                {
                    "sent": "Let's extrapolate, and I calculated five days per woman for getting mammography over 10 year.",
                    "label": 1
                },
                {
                    "sent": "I was accused of minimizing the benef.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "But I said a way to understand the risk is a relate them to other risks and one of the things I said was that.",
                    "label": 1
                },
                {
                    "sent": "This was equivalent, getting eschewing mammography in the 40s was equivalent to gaining.",
                    "label": 1
                },
                {
                    "sent": "2 ounces of body weight.",
                    "label": 0
                },
                {
                    "sent": "And that really was my undoing.",
                    "label": 0
                },
                {
                    "sent": "I.",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "In spite of the evidence and the expert panel, the US Senate.",
                    "label": 1
                },
                {
                    "sent": "Voted 98 to 0 dictating that mammography would be effective for women in their 40s and I am not.",
                    "label": 0
                },
                {
                    "sent": "That's not a typo.",
                    "label": 1
                },
                {
                    "sent": "If you read the resolution, it was essentially telling God, you know that mammography had to be effective.",
                    "label": 0
                },
                {
                    "sent": "But more importantly, they withheld the NCIS budget, National Cancer Institute's budget until the NCI agreed to recommend screening for women in their 40s, so naturally they wanted to continue to exist, and so they did.",
                    "label": 0
                }
            ]
        },
        "clip_24": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "I'm the Bayes estimates again.",
                    "label": 1
                },
                {
                    "sent": "In 2009 these were updated.",
                    "label": 0
                },
                {
                    "sent": "Where do you suppose they went?",
                    "label": 0
                },
                {
                    "sent": "Notice member Canada was down here.",
                    "label": 0
                },
                {
                    "sent": "And we predicted it was was here.",
                    "label": 0
                },
                {
                    "sent": "There is the update.",
                    "label": 0
                },
                {
                    "sent": "Ostergotland here Gothenberg, which was way up here, so it's an empirical evidence of the shrinkage.",
                    "label": 0
                },
                {
                    "sent": "For those astute among you, you may have seen.",
                    "label": 0
                },
                {
                    "sent": "That we lost our S innocence.",
                    "label": 0
                },
                {
                    "sent": "Supposed to be funny, but.",
                    "label": 0
                },
                {
                    "sent": "So we lost our ask where did it go?",
                    "label": 0
                },
                {
                    "sent": "It went way off to the side, so this is stokholm and it turned out in stock.",
                    "label": 0
                }
            ]
        },
        "clip_25": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "At home there were many more deaths in the control group breast cancer deaths than you could have predicted, so it's like, you know, regression to the mean.",
                    "label": 0
                },
                {
                    "sent": "But then there's Wayne Gretzky who doesn't request to.",
                    "label": 0
                },
                {
                    "sent": "The main Stockholm didn't regress to the mean.",
                    "label": 0
                },
                {
                    "sent": "The 2009 this thing about brawling.",
                    "label": 0
                }
            ]
        },
        "clip_26": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Over mammography Task Force employed modeling.",
                    "label": 0
                },
                {
                    "sent": "An randomized control trials to make their recommendation and their recommendation was the same as the recommendation we made 12 years earlier.",
                    "label": 0
                }
            ]
        },
        "clip_27": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "This modeling included one Bayesian model.",
                    "label": 1
                },
                {
                    "sent": "An MD Anderson model.",
                    "label": 0
                },
                {
                    "sent": "And I'll tell you about that.",
                    "label": 0
                },
                {
                    "sent": "The reactions to that as.",
                    "label": 0
                }
            ]
        },
        "clip_28": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Of course, recommendation at the Times said the new guidelines draw opposition spark heated debate.",
                    "label": 1
                },
                {
                    "sent": "The Globe says breast can egressed screening advice upended and there were lots of charges at the time.",
                    "label": 0
                },
                {
                    "sent": "I don't know if you remember death squads, so the charges was.",
                    "label": 0
                },
                {
                    "sent": "This was an Obama death squad keeping women from getting these life saving things.",
                    "label": 0
                }
            ]
        },
        "clip_29": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So the models that they used was from sisnett and system that is based on the following.",
                    "label": 0
                }
            ]
        },
        "clip_30": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This is a trends in breast cancer mortality.",
                    "label": 0
                },
                {
                    "sent": "Overtime, it's actually here broken out by race, but you see for the whites, which is the biggest group.",
                    "label": 0
                },
                {
                    "sent": "The drop is substantial.",
                    "label": 0
                }
            ]
        },
        "clip_31": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Similarly, in UK the drop between 1990 and 2007 was 36%.",
                    "label": 0
                },
                {
                    "sent": "So what's causing that?",
                    "label": 0
                },
                {
                    "sent": "And the screening people said this is screening mammography, because screening came in in this.",
                    "label": 0
                },
                {
                    "sent": "The treatment people said this is treatment.",
                    "label": 0
                },
                {
                    "sent": "Because script treatment got very much better, including tamoxifen, including chemotherapy in this same.",
                    "label": 0
                },
                {
                    "sent": "So sisnett was a group of seven model is funded by the the NCI to model this process.",
                    "label": 0
                }
            ]
        },
        "clip_32": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And we publish our results and the New England Journal of Medicine and my favorite.",
                    "label": 0
                }
            ]
        },
        "clip_33": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "A headline was from CNN.",
                    "label": 0
                },
                {
                    "sent": "Statistical blitz helps pin down mammography benefits new.",
                    "label": 0
                }
            ]
        },
        "clip_34": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Times editorial these are some of the data we used.",
                    "label": 0
                },
                {
                    "sent": "The everybody opened up their balls of data, the CDC, the NCI, various other groups.",
                    "label": 0
                }
            ]
        },
        "clip_35": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Unfortunately, we don't have in the United States a database like they have in Scandinavian countries where you can follow the same women over time to see what happened.",
                    "label": 0
                },
                {
                    "sent": "You know how they were treated or how long they lived.",
                    "label": 0
                },
                {
                    "sent": "We had only cross sectional data so we knew who got you know what the proportion of women were that got tamoxifen.",
                    "label": 0
                },
                {
                    "sent": "We knew you know what their ages were.",
                    "label": 0
                },
                {
                    "sent": "We knew that screened how frequently they get screened etc.",
                    "label": 0
                },
                {
                    "sent": "But we didn't know the two things together.",
                    "label": 0
                }
            ]
        },
        "clip_36": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "This was a I had to work hard to get my coauthors to understand and to agree to put this in the paper.",
                    "label": 0
                },
                {
                    "sent": "This was a.",
                    "label": 0
                },
                {
                    "sent": "A kernel estimate estimation for the major things that we were addressing.",
                    "label": 0
                },
                {
                    "sent": "This is the reduction in breast cancer mortality due to screening.",
                    "label": 1
                },
                {
                    "sent": "This is the reduction due to Agilent treatment and we had the individual models that were spread over the board.",
                    "label": 0
                },
                {
                    "sent": "Naturally they were different.",
                    "label": 0
                },
                {
                    "sent": "This is model M for MD Anderson.",
                    "label": 0
                },
                {
                    "sent": "This is Rochester Erazmus, Wisconsin, Georgetown, Stanford, Dana Farber.",
                    "label": 0
                },
                {
                    "sent": "Everyone except Model M was a point estimate.",
                    "label": 0
                },
                {
                    "sent": "And I wanted to convey the variability in the modeling by taking this rather gross kernel estimate.",
                    "label": 1
                },
                {
                    "sent": "It shows kind of a negative trend, which is sort of expected, because if something is not due to screening, then it's due to something else.",
                    "label": 0
                },
                {
                    "sent": "Maybe it's treatment.",
                    "label": 0
                }
            ]
        },
        "clip_37": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I'm so I did the same thing for Model M because Model M is really many models.",
                    "label": 0
                },
                {
                    "sent": "We do lots of simulations and if we don't match mortality then we reject it.",
                    "label": 0
                },
                {
                    "sent": "If we do then we accept it and we accept the parameters that we use to do the simulation.",
                    "label": 0
                },
                {
                    "sent": "So we use using Bayes rule and interesting and not typical way.",
                    "label": 0
                },
                {
                    "sent": "You can't simply write down a likelihood function for example.",
                    "label": 0
                }
            ]
        },
        "clip_38": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And so this was ignore the letters for a minute.",
                    "label": 0
                },
                {
                    "sent": "These were the models.",
                    "label": 0
                },
                {
                    "sent": "This was the same thing I did for our many models that we'd accepted in the.",
                    "label": 0
                },
                {
                    "sent": "MD Anderson simulations.",
                    "label": 0
                },
                {
                    "sent": "And then I plotted the other models on it and notice that we incorporated all of the models in our uncertainty.",
                    "label": 0
                },
                {
                    "sent": "There was some sort of proud of this.",
                    "label": 0
                },
                {
                    "sent": "There was.",
                    "label": 0
                }
            ]
        },
        "clip_39": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Norway did a study where they actually tried to separate separate out for their database.",
                    "label": 0
                },
                {
                    "sent": "The two things and notice where it went.",
                    "label": 0
                },
                {
                    "sent": "Smack on top of the M they they determined about a 10 percent 10% of the drop was due to.",
                    "label": 0
                },
                {
                    "sent": "10% of the drop was due to screening 20% of the drop is due to.",
                    "label": 1
                },
                {
                    "sent": "Agement therapy",
                    "label": 0
                }
            ]
        },
        "clip_40": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Conclusions from model M. Bayesian approach ideally suited for comparative effectiveness research.",
                    "label": 1
                },
                {
                    "sent": "If you know what that means, or even if you don't know what it means.",
                    "label": 0
                },
                {
                    "sent": "The Bayesian approach encompasses the other six models, probability distributions of parameters are necessary for assessing predictive uncertainty.",
                    "label": 1
                }
            ]
        },
        "clip_41": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Now.",
                    "label": 0
                },
                {
                    "sent": "I would I dredge this up for the occasion.",
                    "label": 0
                },
                {
                    "sent": "To demonstrate to you my knowledge of Japanese.",
                    "label": 0
                }
            ]
        },
        "clip_42": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Seriously, I'm told that this says the coming Bayesian tsunami of clinical development.",
                    "label": 1
                },
                {
                    "sent": "And for those of many of you who speak Japanese, if it in fact says pay no attention to this idiot.",
                    "label": 0
                },
                {
                    "sent": "Then please don't tell me.",
                    "label": 0
                },
                {
                    "sent": "So this is the changing attitude in the medical world generally about the Bayesian approach and looking for something better.",
                    "label": 0
                },
                {
                    "sent": "We've achieved this level, the randomized trial, and we sort of complacent in it.",
                    "label": 0
                },
                {
                    "sent": "I mean, after all, the randomized trial is over 60 years old, what other innovation do you know has remained essentially unchanged for 60 years?",
                    "label": 0
                },
                {
                    "sent": "Think about electronics.",
                    "label": 0
                },
                {
                    "sent": "We are complacent with this level and to take it beyond is difficult because they worry that you're going to be throwing out the baby for the bathwater.",
                    "label": 0
                }
            ]
        },
        "clip_43": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Janet Woodcock, who is the director at the time and still is of the Center for Drugs at the FDA, which is very powerful person, was lamenting the sorry straight.",
                    "label": 0
                },
                {
                    "sent": "The sorry state of drug development generally and suggested that the improved utilization of adaptive and Bayesian methods could help resolve the low success rate and the expense of phase three clinical trials.",
                    "label": 1
                },
                {
                    "sent": "The latest estimate of the cost for developing a drug is 1.8 billion dollars.",
                    "label": 0
                },
                {
                    "sent": "And much of that is in phase three, and much of it due to the fact that.",
                    "label": 0
                },
                {
                    "sent": "You know many of the drugs fail, and so you have to pay for one with the other.",
                    "label": 0
                }
            ]
        },
        "clip_44": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Current use of Bayesian designs at MD Anderson.",
                    "label": 1
                },
                {
                    "sent": "Since I got there in 99, we've had over 300 trials designed and run.",
                    "label": 0
                },
                {
                    "sent": "Most of them run.",
                    "label": 0
                },
                {
                    "sent": "And the accent on the run.",
                    "label": 0
                },
                {
                    "sent": "I mean a lot lot of things that you read in the Bayesian literature is it would be great to do this trial.",
                    "label": 0
                },
                {
                    "sent": "But of course nobody's ever done that trial.",
                    "label": 0
                },
                {
                    "sent": "We've designed trials that we've actually run device companies.",
                    "label": 0
                },
                {
                    "sent": "Many, many designed by Berry consultants that have been over 25 successful approvals of devices taking exclusively a Bayesian approach.",
                    "label": 0
                },
                {
                    "sent": "I'll give you one example.",
                    "label": 0
                },
                {
                    "sent": "Drug companies, most of the Top 40 companies are taking the Bayesian approach, sometimes in a wholehearted way.",
                    "label": 0
                },
                {
                    "sent": "Entire programs are taking a Bayesian approach.",
                    "label": 0
                },
                {
                    "sent": "Sometimes it's they just getting their toes in the water so that if this train leaves the station with the force that some people think it's going to leave, they want to be on it.",
                    "label": 0
                }
            ]
        },
        "clip_45": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Some areas of application, essentially every area of application just to contrast on koleji and migraine on koleji.",
                    "label": 1
                },
                {
                    "sent": "The endpoints are usually long and coming as you get information.",
                    "label": 0
                },
                {
                    "sent": "It takes a long time to get information about what the how the drug was doing.",
                    "label": 0
                },
                {
                    "sent": "An individual patient with migraine, the registration endpoint, the endpoint that the FDA uses to make a decision is 2 hours pain free, so it's essentially immediate information.",
                    "label": 0
                }
            ]
        },
        "clip_46": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "These are in my sort of rough order of communists, Bayesian adaptive trials stopping early or late.",
                    "label": 1
                },
                {
                    "sent": "Sometimes you get to the end of the trial and you wish it weren't over because you don't know the answer, and so you build in the possibility of extending accrual.",
                    "label": 0
                },
                {
                    "sent": "Are those finding the example that I mentioned that Peter and I designed for Pfizer and Stroke was dose finding seamless phases where you move from one drug development sort of funny?",
                    "label": 0
                },
                {
                    "sent": "At some point you say now I know something.",
                    "label": 0
                },
                {
                    "sent": "Like you say, now I know what the dose is.",
                    "label": 0
                },
                {
                    "sent": "Just take just thinking like a Bayesian.",
                    "label": 0
                },
                {
                    "sent": "You never know anything.",
                    "label": 0
                },
                {
                    "sent": "You have a probability distribution and incorporating the information that you have in terms of a probability distribution let's you answer the question you know, do I want to go to an additional?",
                    "label": 0
                },
                {
                    "sent": "Do I want to run this additional trial?",
                    "label": 0
                },
                {
                    "sent": "What type of trial should I be running in view of the evidence that I have so far?",
                    "label": 0
                },
                {
                    "sent": "But the seamless phases where you put the things together you find the dose you morph into a setting where you randomizing to equally, or you identify some other aspect of the drug that you're like how to use it.",
                    "label": 0
                },
                {
                    "sent": "Population finding and this is becoming incredibly important in the world of medicine we recognize and cancer, for example, we recognize that were over treating most people.",
                    "label": 0
                },
                {
                    "sent": "If you have cancer.",
                    "label": 0
                },
                {
                    "sent": "You're more likely to get too much therapy.",
                    "label": 0
                },
                {
                    "sent": "We don't know who, so it's to try to identify which subset of patient is benefiting from which therapy, and it is this aspect that is really grabbed ahold of the Bayesian approach and is dragging it into the 21st century.",
                    "label": 0
                },
                {
                    "sent": "Adaptive randomization ramping up accrual.",
                    "label": 1
                }
            ]
        },
        "clip_47": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So why do people do this?",
                    "label": 0
                },
                {
                    "sent": "Smaller trials, usually more accurate conclusions 'cause you know you you.",
                    "label": 1
                },
                {
                    "sent": "It's like driving a car with your eyes open instead of closed.",
                    "label": 0
                },
                {
                    "sent": "You're looking at the data, and so you know when you get there, and you know when you want to turn off.",
                    "label": 0
                },
                {
                    "sent": "Addresses more questions, so we look at all sorts of questions, how you know how to use the drug.",
                    "label": 0
                },
                {
                    "sent": "Is there a subset of the patients that benefit?",
                    "label": 0
                },
                {
                    "sent": "It should be used in combination with other drugs, for example.",
                    "label": 0
                },
                {
                    "sent": "And maybe better treatment of patients in the trial harkening back to the bandit problem approach where I was explicitly modeling.",
                    "label": 0
                },
                {
                    "sent": "You know, treating patients effectively over the course of these hundred coin tosses, and so it's coming.",
                    "label": 0
                },
                {
                    "sent": "You know this is a this is a major.",
                    "label": 0
                }
            ]
        },
        "clip_48": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Medical Journal that last week published a paper adaptive.",
                    "label": 0
                },
                {
                    "sent": "Clinical trials is a partial remedy for the therapeutic misconception.",
                    "label": 0
                },
                {
                    "sent": "Therapeutic misconception is most people in clinical trials think that they're getting their there and they're getting the benefit of experts and are treated effectively.",
                    "label": 0
                },
                {
                    "sent": "It ain't so this is to try to.",
                    "label": 0
                },
                {
                    "sent": "Make it at least partially so.",
                    "label": 0
                }
            ]
        },
        "clip_49": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So it's related to bandit problems.",
                    "label": 0
                },
                {
                    "sent": "This is an example trial that I do.",
                    "label": 0
                }
            ]
        },
        "clip_50": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Signed shortly after I got the MD Anderson.",
                    "label": 0
                },
                {
                    "sent": "This is a drug called trucks.",
                    "label": 0
                },
                {
                    "sent": "Aside of being in acute myeloid leukemia, the principle principle investigator said I wanted.",
                    "label": 0
                },
                {
                    "sent": "Do a trial with 75 patients and I'll put a third of them in each of three arms.",
                    "label": 0
                },
                {
                    "sent": "I'll take trucks aside of being and I'll combine it with our one of our two agents that we use Standard Lee in this disease.",
                    "label": 0
                },
                {
                    "sent": "Idarubicin and Ara C, So I'll give a third of the patients Idarubicin and Ara.",
                    "label": 0
                },
                {
                    "sent": "See the standard.",
                    "label": 0
                },
                {
                    "sent": "I'll give a third of the patients idarubicin and truck society being.",
                    "label": 0
                },
                {
                    "sent": "I'll give a third of the patients our C and trucks aside to be.",
                    "label": 0
                },
                {
                    "sent": "And I said, well, OK, but why don't we look at the data?",
                    "label": 0
                },
                {
                    "sent": "An if one of the experimental arms is doing poorly, let's.",
                    "label": 0
                },
                {
                    "sent": "Down weight its probability, and if it's doing sufficiently poorly, will shelve it.",
                    "label": 0
                },
                {
                    "sent": "And similarly for the other experimental arms.",
                    "label": 0
                },
                {
                    "sent": "And if both aren't experimental, arms are doing very poorly.",
                    "label": 0
                },
                {
                    "sent": "At the end, we'll just.",
                    "label": 0
                },
                {
                    "sent": "We'll just call it.",
                    "label": 0
                }
            ]
        },
        "clip_51": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Calling an end, that is will do adaptive randomization.",
                    "label": 0
                }
            ]
        },
        "clip_52": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So we assign higher probability to better performing therapies.",
                    "label": 1
                },
                {
                    "sent": "It turned out in the trial number.",
                    "label": 0
                },
                {
                    "sent": "Keep in mind 75 after the 24th patient was treated.",
                    "label": 0
                },
                {
                    "sent": "We dropped try to the trucks aside of being idarubicin, THTR, and you'll see why after the 34th patient was treated.",
                    "label": 0
                },
                {
                    "sent": "We dropped the other arm and therefore stopped the trial.",
                    "label": 0
                },
                {
                    "sent": "So 34 in comparison with 75 and these were the final res.",
                    "label": 0
                }
            ]
        },
        "clip_53": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "What's the TI arm?",
                    "label": 0
                },
                {
                    "sent": "Had been given to five patients, none of whom achieved a complete remission, which was the end point of the trial and TA it was 27% three out of 11, and in IA it was 56%, which was standard.",
                    "label": 0
                },
                {
                    "sent": "I should.",
                    "label": 0
                },
                {
                    "sent": "Say it's not quite so neat.",
                    "label": 0
                },
                {
                    "sent": "By the way, the PPI submit submitted this paper to the Journal Blood, which is an important Journal in leukemia, and they said you can't learn anything from 5 patients.",
                    "label": 0
                },
                {
                    "sent": "And so I said, Frank, why don't you write to him and say if he gets to this disease, we have a treatment for him?",
                    "label": 0
                },
                {
                    "sent": "But he didn't do that.",
                    "label": 0
                },
                {
                    "sent": "Submit it to the General clinical oncology and they said it's clear that the drug is a dud, but will publish your paper because you you exposed many fewer patients to inferior therapy.",
                    "label": 0
                },
                {
                    "sent": "The rest of the story is that the drug company didn't believe this.",
                    "label": 0
                },
                {
                    "sent": "And so they managed a phase three trial.",
                    "label": 0
                },
                {
                    "sent": "And the phase three trial was closed.",
                    "label": 0
                },
                {
                    "sent": "You know, with like 200 patients accrued, you know not nearly what the maximum number was by the data Monitoring Committee because the drug was killing patients.",
                    "label": 0
                },
                {
                    "sent": "So they should have listened, but it makes you aware that this is not such an easy question.",
                    "label": 0
                },
                {
                    "sent": "What what kind of a randomization should you do?",
                    "label": 0
                },
                {
                    "sent": "If we had exposed all 75 patients in the way that Frank originally suggested?",
                    "label": 0
                },
                {
                    "sent": "Maybe the company would have been persuaded.",
                    "label": 0
                },
                {
                    "sent": "Maybe we would have killed enough people that they would have been persuaded not to run this next trial.",
                    "label": 0
                },
                {
                    "sent": "So it's it's a very dicey question.",
                    "label": 0
                },
                {
                    "sent": "I don't mean to make it as simple as I perhaps did, but.",
                    "label": 0
                }
            ]
        },
        "clip_54": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "But Frank Giles was persuaded.",
                    "label": 0
                },
                {
                    "sent": "I see no rationale to further delay moving to these designs, said Doctor Giles, who's currently involved in eight Bayesian based leukemia studies.",
                    "label": 1
                },
                {
                    "sent": "They are more ethical.",
                    "label": 1
                },
                {
                    "sent": "More patient friendly, more conserving of resources and more statistically desirable.",
                    "label": 0
                }
            ]
        },
        "clip_55": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So, um, Myquest talked about simulations.",
                    "label": 0
                },
                {
                    "sent": "Christian talked about simulations.",
                    "label": 0
                },
                {
                    "sent": "We do simulations out the wazoo.",
                    "label": 0
                },
                {
                    "sent": "You're going to hate this, but one of the things that we do is we calculate type 1 error rate.",
                    "label": 0
                },
                {
                    "sent": "So we can't.",
                    "label": 0
                },
                {
                    "sent": "We have a very complicated design, but we generate under the null hypothesis to show what the Type 1 error rate is.",
                    "label": 0
                },
                {
                    "sent": "And sometimes if this is a registration trial to trial, it's going to go to the FDA.",
                    "label": 0
                },
                {
                    "sent": "We have to modify the design.",
                    "label": 0
                },
                {
                    "sent": "To get the Type 1 error rate less than point of 025, what that means is.",
                    "label": 0
                },
                {
                    "sent": "That we've gone through this Bayesian machinery.",
                    "label": 0
                },
                {
                    "sent": "We built this wonderful, clever design.",
                    "label": 0
                },
                {
                    "sent": "But then we made it frequentist.",
                    "label": 0
                },
                {
                    "sent": "So other things as well.",
                    "label": 0
                }
            ]
        },
        "clip_56": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Two recent can't read that OK, what is it?",
                    "label": 0
                },
                {
                    "sent": "15 OK, two recent clinical trials with smaller sample size.",
                    "label": 1
                },
                {
                    "sent": "One you they both use Bayesian predicted probabilities actually and they both use Lange tuddal modeling, but just two high profile.",
                    "label": 0
                },
                {
                    "sent": "Bayesian trials this one again.",
                    "label": 0
                }
            ]
        },
        "clip_57": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Published in JAMA generally.",
                    "label": 0
                },
                {
                    "sent": "American Medical Association, the abstract says.",
                    "label": 0
                }
            ]
        },
        "clip_58": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Respective multicenter randomized 2 to one unblinded Bayesian designed study conducted at 19 hospitals of 167 patients.",
                    "label": 0
                },
                {
                    "sent": "So this was about 1/3 less than the maximum the company approached us because accrual was slow and it was going to take forever to for them to finish the trial.",
                    "label": 0
                },
                {
                    "sent": "Could we convert it into a Bayesian trial an we did and we did Lange tuddal modeling.",
                    "label": 0
                },
                {
                    "sent": "To get early information an we did predicted probabilities such that if we predicted that the answer was going to be clear with additional follow-up, we'd stop the study at that point.",
                    "label": 0
                },
                {
                    "sent": "And we did submit it to this.",
                    "label": 0
                },
                {
                    "sent": "The Journal and the Journal said.",
                    "label": 0
                },
                {
                    "sent": "You did a Bayesian approach.",
                    "label": 0
                },
                {
                    "sent": "You have the word Bayesian or abstract.",
                    "label": 0
                },
                {
                    "sent": "We don't use the word Bayesian are abstracts.",
                    "label": 0
                },
                {
                    "sent": "Now you can imagine.",
                    "label": 0
                },
                {
                    "sent": "How livid I was.",
                    "label": 0
                },
                {
                    "sent": "And I said, maybe you don't understand.",
                    "label": 0
                },
                {
                    "sent": "This trial was designed by a baby from a Bayesian perspective.",
                    "label": 0
                },
                {
                    "sent": "The protocol was Bayesian throughout.",
                    "label": 0
                },
                {
                    "sent": "It was designed in coordination with the FDA.",
                    "label": 0
                },
                {
                    "sent": "It was approved for marketing by the FDA on the basis of an expert panel.",
                    "label": 0
                },
                {
                    "sent": "You have an obligation as a medical Journal.",
                    "label": 0
                },
                {
                    "sent": "To adhere to the Bible of Medicine, which is the protocol, therefore, you must use the Bayesian approach and the calculations and in the abstract.",
                    "label": 0
                },
                {
                    "sent": "Of course I thought I was whistling Dixie.",
                    "label": 0
                },
                {
                    "sent": "That's funny.",
                    "label": 0
                },
                {
                    "sent": "I thought I was, you know.",
                    "label": 0
                },
                {
                    "sent": "But I embarrassed enough so that there it is.",
                    "label": 0
                },
                {
                    "sent": "JAMA used the word Bayesian and also the primary analysis are all Bayesian we did.",
                    "label": 0
                },
                {
                    "sent": "They did ask us to say, well, what would the analogue in the frequentist B so that we can communicate better to our audience.",
                    "label": 0
                },
                {
                    "sent": "So we did have some analogs.",
                    "label": 0
                },
                {
                    "sent": "But you know, going in the other direction, taking the data and doing a Bayesian approach.",
                    "label": 0
                },
                {
                    "sent": "If the data were collected as a frequentist is easy going in the other direction is not so easy.",
                    "label": 0
                },
                {
                    "sent": "Because you don't know what the.",
                    "label": 0
                },
                {
                    "sent": "You know what?",
                    "label": 0
                },
                {
                    "sent": "The conference, what the actual design of the experiment was.",
                    "label": 0
                },
                {
                    "sent": "It wasn't incorporated into the frequentist approach, so we did nominal things.",
                    "label": 0
                }
            ]
        },
        "clip_59": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "That I mentioned oncology.",
                    "label": 0
                },
                {
                    "sent": "Perhaps the hardest group in oncology to study using an adaptive is.",
                    "label": 0
                },
                {
                    "sent": "Early stage breast cancer in elderly women because it tends to be a disease that's innocuous.",
                    "label": 0
                },
                {
                    "sent": "In fact, most of it is overdiagnosed patient would never.",
                    "label": 0
                },
                {
                    "sent": "Find out that she had the disease.",
                    "label": 0
                },
                {
                    "sent": "If you didn't do mammograms sort.",
                    "label": 0
                },
                {
                    "sent": "Harken back.",
                    "label": 0
                },
                {
                    "sent": "And so the events are not very long and coming.",
                    "label": 0
                },
                {
                    "sent": "I mean, I'm very long incoming.",
                    "label": 0
                },
                {
                    "sent": "And it took me awhile to build this design because the NCI said you got to do a trial with 2000 patients.",
                    "label": 0
                },
                {
                    "sent": "And I said we don't have 2000 patients, will never finish the trial if we have to do 2000 patients.",
                    "label": 0
                }
            ]
        },
        "clip_60": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Was a long time, but I finally had this inspiration that I said, OK, here's what we'll do.",
                    "label": 0
                },
                {
                    "sent": "We'll go to 600 patients will do Bayesian predictive calculations.",
                    "label": 0
                },
                {
                    "sent": "If with additional follow-up, the probability of having a conclusion.",
                    "label": 0
                },
                {
                    "sent": "Yay or nay?",
                    "label": 0
                },
                {
                    "sent": "In terms of the.",
                    "label": 0
                },
                {
                    "sent": "Objective of the trial will stop accrual will follow the patients for that period of time and then publish the results, and so they finally agreed that we could do that.",
                    "label": 0
                },
                {
                    "sent": "And so in clinicaltrials.gov it said, under sample size it said this usually look, it says it's a 2000 patient trial or another one is a 500 patient trial, this one said.",
                    "label": 0
                },
                {
                    "sent": "The sample size is 600 to 1800.",
                    "label": 1
                },
                {
                    "sent": "Surprise when we looked at six 600.",
                    "label": 0
                },
                {
                    "sent": "The Bayesian predictive calculation was such that we were going to have an answer.",
                    "label": 0
                },
                {
                    "sent": "We stopped accrual at 600.",
                    "label": 0
                },
                {
                    "sent": "Final total was 636 I think.",
                    "label": 0
                },
                {
                    "sent": "We followed for the additional 2 years Anne published in.",
                    "label": 0
                },
                {
                    "sent": "The New England Journal of positive results.",
                    "label": 0
                },
                {
                    "sent": "Or to quote one of my favorite baseball players who was.",
                    "label": 0
                },
                {
                    "sent": "Commentating on a baseball game and somebody said something and it had appeared in ESPN, the magazine and he said, well, what do you expect?",
                    "label": 0
                },
                {
                    "sent": "That's not the New England Journal of Science?",
                    "label": 0
                },
                {
                    "sent": "Joe Morgan, for those of you that know baseball.",
                    "label": 0
                },
                {
                    "sent": "I'm.",
                    "label": 0
                }
            ]
        },
        "clip_61": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So these are two of several federal grants that very consultants has and I want to highlight the first one.",
                    "label": 0
                },
                {
                    "sent": "Because it couldn't have happened.",
                    "label": 0
                },
                {
                    "sent": "20 years ago it couldn't have happened.",
                    "label": 0
                },
                {
                    "sent": "10 years ago it probably couldn't have happened five years ago, but Corey is you may have read about.",
                    "label": 0
                },
                {
                    "sent": "Obama in a stimulation package.",
                    "label": 0
                },
                {
                    "sent": "He assigned 1.1 billion dollars to comparative effectiveness research and that went to establishing this Institute personalized.",
                    "label": 0
                },
                {
                    "sent": "This personalized center of outcomes researched Institute.",
                    "label": 0
                },
                {
                    "sent": "They sponsor trials.",
                    "label": 0
                },
                {
                    "sent": "And some of them they expect are going to be adaptive, so they put out an RFA request for applications and we said will really willing to write your guidance for adaptive designs.",
                    "label": 0
                },
                {
                    "sent": "Now mind, you were known as Bayesian adaptive and not as adaptive.",
                    "label": 0
                },
                {
                    "sent": "And so we didn't expect we'd get it, but they agreed that we were the authorities on adaptive design generally.",
                    "label": 0
                },
                {
                    "sent": "And so we got.",
                    "label": 0
                },
                {
                    "sent": "We've actually now written the adaptive design guidance for clinical trials for Cory.",
                    "label": 0
                },
                {
                    "sent": "So it's sort of a big deal for Bayesians.",
                    "label": 0
                },
                {
                    "sent": "We talk about non Bayesian adaptive designs too.",
                    "label": 0
                },
                {
                    "sent": "And we have with a group at the University of Michigan a regulatory science award.",
                    "label": 0
                },
                {
                    "sent": "the FDA, NIH, funded four regulatory science grants and one of 'em was with very consultants where we design the trials for this neurology group and using a Bayesian adaptive approach, they run the trials and we address the barriers.",
                    "label": 0
                }
            ]
        },
        "clip_62": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This is.",
                    "label": 0
                }
            ]
        },
        "clip_63": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Roger Lewis talking our current approach to trials is horribly inefficient.",
                    "label": 1
                },
                {
                    "sent": "We need to do something better.",
                    "label": 0
                },
                {
                    "sent": "Said Roger Lewis, who helps advisor company, called Very Consultants.",
                    "label": 0
                }
            ]
        },
        "clip_64": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Lewis and Berry, along with emergency physician William Barson, the University of Michigan will be studying whether adaptive trial designs that incorporate new information in midcourse can answer medical questions.",
                    "label": 1
                },
                {
                    "sent": "They also want to learn what concerns researchers might have about this approach.",
                    "label": 0
                },
                {
                    "sent": "So what are the barriers?",
                    "label": 0
                },
                {
                    "sent": "What are the problems about doing Bayesian things, for example, and you will not be surprised to know that the biggest barriers we find with statisticians.",
                    "label": 0
                },
                {
                    "sent": "So the last thing I want to talk about.",
                    "label": 0
                }
            ]
        },
        "clip_65": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Is this trial called I Spy 2?",
                    "label": 0
                }
            ]
        },
        "clip_66": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This is Janet Woodcock again writing in the New England Journal of Medicine.",
                    "label": 0
                }
            ]
        },
        "clip_67": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And she advertised I spy two as this groundbreaking trial and breast cancer to predict drug responsiveness based on the presence or absence of genetic and biological markers.",
                    "label": 0
                },
                {
                    "sent": "I spy two is a Bayesian trial.",
                    "label": 0
                },
                {
                    "sent": "I designed it and it's currently running.",
                    "label": 0
                },
                {
                    "sent": "It was advertised in an FDA.",
                    "label": 0
                }
            ]
        },
        "clip_68": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Document here, which I won't go into.",
                    "label": 0
                }
            ]
        },
        "clip_69": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Anne.",
                    "label": 0
                }
            ]
        },
        "clip_70": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Wall Street Journal had a Saturday review essay.",
                    "label": 0
                }
            ]
        },
        "clip_71": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Describing it in here is a. Graph that comes from that.",
                    "label": 0
                }
            ]
        },
        "clip_72": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Article new trial design using genetic profiles to highlight biomarker differences among patients and to match drugs to patients with biomarkers that benefit.",
                    "label": 0
                }
            ]
        },
        "clip_73": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The idea is this is the status quo.",
                    "label": 0
                },
                {
                    "sent": "We do small phase two trials, sometimes not even randomized, and then do 3000 patient phase three trials.",
                    "label": 0
                },
                {
                    "sent": "Leading to this horrible success rate in phase three, an horribly expensive success rate in phase three.",
                    "label": 0
                },
                {
                    "sent": "The idea is to do smaller, more focused trials.",
                    "label": 0
                },
                {
                    "sent": "So I dunno if you can identify and Janet Woodcock gets this in spades.",
                    "label": 0
                },
                {
                    "sent": "If you can identify the subset of patients.",
                    "label": 0
                },
                {
                    "sent": "Who benefit from a drug and not be treating those that don't benefit from the drug?",
                    "label": 0
                },
                {
                    "sent": "You can run a much smaller trial.",
                    "label": 0
                },
                {
                    "sent": "Which is good for everybody.",
                    "label": 0
                },
                {
                    "sent": "It's good for the patients that are being treated in the trial.",
                    "label": 0
                },
                {
                    "sent": "It's good for the patients that are not being treated in the trial.",
                    "label": 0
                },
                {
                    "sent": "It's good for the patients who come afterwards because you're getting an answer much more quickly.",
                    "label": 0
                },
                {
                    "sent": "And finally, it's good for the economy because you're not spending this 1.8 billion dollars.",
                    "label": 0
                },
                {
                    "sent": "It's a small, focused, inexpensive, but compelling phase three trial.",
                    "label": 0
                },
                {
                    "sent": "And agreed to by the FDA.",
                    "label": 0
                }
            ]
        },
        "clip_74": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So here's a cartoon.",
                    "label": 0
                },
                {
                    "sent": "This is the standard approach.",
                    "label": 0
                }
            ]
        },
        "clip_75": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Either you do a single arm trial or you randomize experimental arm and standard and a big deal here is that the population is homogeneous.",
                    "label": 0
                }
            ]
        },
        "clip_76": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The consequences that Onkologie has the worst success rate in phase three.",
                    "label": 0
                },
                {
                    "sent": "None are very good, but oncology is the worst one in three trials succeed.",
                    "label": 0
                }
            ]
        },
        "clip_77": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I spy two is a process.",
                    "label": 0
                },
                {
                    "sent": "We add arms, subtract arms, we went, but the important thing and we do adaptive randomization.",
                    "label": 0
                },
                {
                    "sent": "The important thing is recognizing the population of patients that is heterogeneous.",
                    "label": 0
                },
                {
                    "sent": "And we're going to select those patients who are benefiting.",
                    "label": 0
                },
                {
                    "sent": "You'll recognize, of course.",
                    "label": 0
                },
                {
                    "sent": "That the false positive rate is huge.",
                    "label": 0
                },
                {
                    "sent": "So the trial is going to be have to be bigger because we have to beat down those false positives at least to some extent.",
                    "label": 0
                },
                {
                    "sent": "Otherwise we'll be making matters worse.",
                    "label": 0
                }
            ]
        },
        "clip_78": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So as we go, perhaps experimental arm two graduates into this small, focused phase three trial, it gets dropped and we continue to adaptively randomize experiment.",
                    "label": 0
                }
            ]
        },
        "clip_79": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "ARM 3 is.",
                    "label": 0
                }
            ]
        },
        "clip_80": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Opt for futility.",
                    "label": 0
                }
            ]
        },
        "clip_81": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "ARM 5 graduates into a different set and the graduation is based on predictive Bayesian calculations of success in Phase three.",
                    "label": 0
                },
                {
                    "sent": "Explicitly looking forward, not only to the rest of the current trial, but also the next trial.",
                    "label": 0
                },
                {
                    "sent": "I.",
                    "label": 0
                }
            ]
        },
        "clip_82": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then we add arms as we go.",
                    "label": 0
                },
                {
                    "sent": "We might have.",
                    "label": 0
                }
            ]
        },
        "clip_83": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Example, an adaptively randomized factor.",
                    "label": 0
                }
            ]
        },
        "clip_84": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Oil design is a subset of the arms.",
                    "label": 0
                }
            ]
        },
        "clip_85": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The goal is 85% success rate in phase three with the focus on patients who benefit so.",
                    "label": 0
                }
            ]
        },
        "clip_86": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "I like approaches.",
                    "label": 0
                },
                {
                    "sent": "We match drugs to biomarker signatures, savings from a common control.",
                    "label": 0
                },
                {
                    "sent": "I mean if you in the standard approach, if you're doing these phase two trial, you know our May versus control arm be versus control arm C versus control separate trials.",
                    "label": 0
                },
                {
                    "sent": "Even before you do anything clever.",
                    "label": 0
                },
                {
                    "sent": "There is an efficiency in having the same control with these various arms.",
                    "label": 0
                },
                {
                    "sent": "Better therapies move through faster, get to other patients more quickly.",
                    "label": 0
                },
                {
                    "sent": "Successful drug biomarker pairs graduate to a small focus, more successful phase three based on Bayesian predicted probabilities and there's offspring of I spy two and everybody wants to do I spy two colorectal cancer and Melanoma lymphoma.",
                    "label": 0
                },
                {
                    "sent": "Alzheimer's disease, HIV, acute heart failure and sorry in H H1N1.",
                    "label": 0
                },
                {
                    "sent": "By that I mean the pandemic flu's.",
                    "label": 0
                },
                {
                    "sent": "Which is a whole different story of trying to set up a clinical trial because you've got to have it ready.",
                    "label": 0
                },
                {
                    "sent": "To go off the block.",
                    "label": 0
                },
                {
                    "sent": "The Spanish flu, for example, 1918, was typical in that the peak mortality.",
                    "label": 0
                },
                {
                    "sent": "Was two months after we knew the flu is there.",
                    "label": 0
                },
                {
                    "sent": "And so you can't wait this time to, you know, develop things.",
                    "label": 0
                },
                {
                    "sent": "So we're developing things in advance and the sorry stands for a severe acute respiratory infection.",
                    "label": 0
                },
                {
                    "sent": "And we're actually going to be running trials.",
                    "label": 0
                },
                {
                    "sent": "International trials in.",
                    "label": 0
                },
                {
                    "sent": "Sorry so.",
                    "label": 0
                }
            ]
        },
        "clip_87": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So here is our rough history of Biostatistics revisited.",
                    "label": 0
                },
                {
                    "sent": "And here is what?",
                    "label": 0
                }
            ]
        },
        "clip_88": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Looks like in the 21st century.",
                    "label": 0
                },
                {
                    "sent": "Thank you very much.",
                    "label": 0
                },
                {
                    "sent": "Questions comments for Don.",
                    "label": 0
                },
                {
                    "sent": "Are you are getting ready for the reception so you think of your comments?",
                    "label": 0
                },
                {
                    "sent": "Let me quickly swing up there.",
                    "label": 0
                },
                {
                    "sent": "Oh sorry.",
                    "label": 0
                },
                {
                    "sent": "Said Carrie.",
                    "label": 0
                },
                {
                    "sent": "OK, we can hear you, yeah.",
                    "label": 0
                },
                {
                    "sent": "So I made a comment that the biggest barriers are in statisticians.",
                    "label": 0
                },
                {
                    "sent": "Can I elaborate?",
                    "label": 0
                },
                {
                    "sent": "No.",
                    "label": 0
                },
                {
                    "sent": "It's very.",
                    "label": 0
                },
                {
                    "sent": "It is very difficult for me to elaborate because there individuals involved.",
                    "label": 0
                },
                {
                    "sent": "It's it's.",
                    "label": 0
                },
                {
                    "sent": "It's a teaching process.",
                    "label": 0
                },
                {
                    "sent": "The stuff that we do is not in the repertoire of statisticians.",
                    "label": 0
                },
                {
                    "sent": "Generally even Bayesian statisticians, it takes an apprentice ship almost to be able to do these things.",
                    "label": 0
                },
                {
                    "sent": "We have some young people in the audience for MD Anderson and you can ask them how they dove into doing clinical trials from a Bayesian perspective, it ain't easy, and it's not something that really anybody learns in their high school.",
                    "label": 0
                },
                {
                    "sent": "Ann, I reason I said high school is where my favorite songs is.",
                    "label": 0
                },
                {
                    "sent": "Paul Simon's.",
                    "label": 0
                },
                {
                    "sent": "Kodachrome when I think back to all the crap I learned in high school, it's a wonder I can think at all.",
                    "label": 0
                },
                {
                    "sent": "We don't learn enough in in our education to be able to do these kinds of things, and so there is a bit of I mean.",
                    "label": 0
                },
                {
                    "sent": "Imagine telling somebody.",
                    "label": 0
                },
                {
                    "sent": "That they're not adaptive.",
                    "label": 0
                },
                {
                    "sent": "It's a hard sell, and so we do it gently, but it's it's a represents a barrier.",
                    "label": 0
                },
                {
                    "sent": "Sneak in a commercial, there's actually an initiative to start the bio Staten Farmer section in Isba, so maybe that can create momentum and for those of you is the Members and interested to support the new section, please hit is by website and under sections.",
                    "label": 0
                },
                {
                    "sent": "There should be a link to support the petition to.",
                    "label": 0
                },
                {
                    "sent": "Launched a new section.",
                    "label": 0
                },
                {
                    "sent": "Yeah, so can I comment too?",
                    "label": 0
                },
                {
                    "sent": "We've had five years of Bayesian Biostatistics at MD Anderson in January, late January, and I've forgotten the dates this year.",
                    "label": 0
                },
                {
                    "sent": "But for those of you that are interested in coming and presenting posters, look for our.",
                    "label": 0
                },
                {
                    "sent": "Our announcements and come or send me an email and I'll tell you what the circumstances are.",
                    "label": 0
                },
                {
                    "sent": "Asian Bio state party.",
                    "label": 0
                },
                {
                    "sent": "Press.",
                    "label": 0
                },
                {
                    "sent": "Outley Type 1 error.",
                    "label": 0
                },
                {
                    "sent": "Simulation Hills there might be many ways that you could adjust the design in order to get a Type 1 error, so could you say a little bit more about how you kind of achieve that?",
                    "label": 0
                },
                {
                    "sent": "Is it systematically or by just playing around with these ones?",
                    "label": 0
                },
                {
                    "sent": "So the question is, I mentioned type 1 error an we sometimes have to go back to the design and what the case that I mentioned was?",
                    "label": 0
                },
                {
                    "sent": "It's a registration trial in order to ensure that we have so called control type one or something I didn't mention was that the FDA has a guidance on adaptive design where their anal about type 1 error.",
                    "label": 0
                },
                {
                    "sent": "I mean, essentially every page they say you gotta control type 1 error and their problems.",
                    "label": 0
                },
                {
                    "sent": "You know with multiplicity is associated with adaptive design.",
                    "label": 0
                },
                {
                    "sent": "So the question is, so how do we do that?",
                    "label": 0
                },
                {
                    "sent": "Suppose we build this really interesting clever design.",
                    "label": 0
                },
                {
                    "sent": "It looks at lots of questions and the Type 1 error.",
                    "label": 0
                },
                {
                    "sent": "The you know the familywise type 1 error is bigger than .025.",
                    "label": 0
                },
                {
                    "sent": "Usually there are almost always a variety of things.",
                    "label": 0
                },
                {
                    "sent": "Be back up.",
                    "label": 0
                },
                {
                    "sent": "There is no single Type 1 error I mentioned.",
                    "label": 0
                },
                {
                    "sent": "For example, accrual rate.",
                    "label": 0
                },
                {
                    "sent": "If the endpoint is a time to event endpoint, accrual rate is critical.",
                    "label": 0
                },
                {
                    "sent": "And if you've got along with so we have to simulate assuming various accrual rates.",
                    "label": 0
                },
                {
                    "sent": "And sometimes the accrual rate if the accrual rate is slow, we get bigger than .025.",
                    "label": 0
                },
                {
                    "sent": "If it's fast, we get less than .025.",
                    "label": 0
                },
                {
                    "sent": "We have to satisfy the FDA in case it's slow.",
                    "label": 0
                },
                {
                    "sent": "So there are a variety of things that we can do.",
                    "label": 0
                },
                {
                    "sent": "Most typically there's a final cut point or final statistical significance.",
                    "label": 0
                },
                {
                    "sent": "You know, or posterior probability that you're claiming in order to have a success, we usually modify that.",
                    "label": 0
                },
                {
                    "sent": "And the way we modify it is typically by trial and error.",
                    "label": 0
                },
                {
                    "sent": "We can't, we almost none of what we do can be done by analytics.",
                    "label": 0
                },
                {
                    "sent": "So we have to do simulation and trial and error is you know as easy as anything.",
                    "label": 0
                },
                {
                    "sent": "You are very specific about using Bashan adaptive designs rather than adaptive, So what are the big differences between a bashan adaptive design and adaptive design in terms of results and in terms of what you can do, so Bayesian designs are better?",
                    "label": 0
                },
                {
                    "sent": "No, I seriously I yeah.",
                    "label": 0
                },
                {
                    "sent": "I mean, I talked about Bayesian adaptive designs because it's what I do.",
                    "label": 0
                },
                {
                    "sent": "The adaptive designs more.",
                    "label": 0
                },
                {
                    "sent": "If you take a Bayesian perspective, you can say what do I want this trial to do?",
                    "label": 0
                },
                {
                    "sent": "What do I want it to be so it has a theme and you can build the trial around that theme?",
                    "label": 0
                },
                {
                    "sent": "And typically when I ask?",
                    "label": 0
                },
                {
                    "sent": "Clients you know what they want the trial to do.",
                    "label": 0
                },
                {
                    "sent": "It's like.",
                    "label": 0
                },
                {
                    "sent": "In a Fusion of things that they would like to know the answers to, remember that the standard approach is you ask one question.",
                    "label": 0
                },
                {
                    "sent": "An you run the trial and you get the answer to that one question.",
                    "label": 0
                },
                {
                    "sent": "They typically have lots of questions so we say keep it coming.",
                    "label": 0
                },
                {
                    "sent": "Will address all of these questions, usually in an efficient way does increase the maximum sample size somewhat because we're asking more questions.",
                    "label": 0
                },
                {
                    "sent": "So a major difference in this is empirically based between the Bayesian and non Bayesian approach is that the Bayesian approach tends to be more complicated because it addresses more things.",
                    "label": 0
                },
                {
                    "sent": "The Bayesian approach tends to be more complicated.",
                    "label": 0
                },
                {
                    "sent": "We look much more frequently.",
                    "label": 0
                },
                {
                    "sent": "In fact, we run some trials where we're looking everyday at the data and modifying.",
                    "label": 0
                },
                {
                    "sent": "You know which way we turn on the basis.",
                    "label": 0
                },
                {
                    "sent": "Most non Bayesian approaches are done analytically.",
                    "label": 0
                },
                {
                    "sent": "So that they are able to do the calculations.",
                    "label": 0
                },
                {
                    "sent": "You know this is multivariate normal that they do.",
                    "label": 0
                },
                {
                    "sent": "And integration under some subset whatever.",
                    "label": 0
                },
                {
                    "sent": "So most of 'em are done analytically, and that's again, it's an empirical observation.",
                    "label": 0
                },
                {
                    "sent": "Probably most of the adapt what is adaptive if you know what a group sequential design is.",
                    "label": 0
                },
                {
                    "sent": "It's a design where you do look at it.",
                    "label": 0
                },
                {
                    "sent": "In the interim analysis to potentially stop the study in announcing results.",
                    "label": 0
                },
                {
                    "sent": "That's adaptive.",
                    "label": 0
                },
                {
                    "sent": "It's a pretty simple adaptation, and so we don't.",
                    "label": 0
                },
                {
                    "sent": "I don't count that as being adapted when we did this pecori guidance, we described the complex adaptive aspects, not the simple ones of the.",
                    "label": 0
                },
                {
                    "sent": "Group sequential if you look at the complex adaptive ones.",
                    "label": 0
                },
                {
                    "sent": "Almost all of those are Bayesian.",
                    "label": 0
                },
                {
                    "sent": "It's hard to design A complicated study from a frequentist perspective that's looking at lots of questions an you know turning the boat as the wind blows in a different direction.",
                    "label": 0
                },
                {
                    "sent": "One more last question for you.",
                    "label": 0
                },
                {
                    "sent": "You hear me, yeah, one of the main traits that at least I feel in regulatory interactions that leads to an instinctive, almost opposition to Bayesian methods is a fear of not incorporating or considering sampling variability or things that could have happened but didn't, and I find it really difficult to.",
                    "label": 0
                },
                {
                    "sent": "Um?",
                    "label": 0
                },
                {
                    "sent": "Let's say discourage this attitude.",
                    "label": 0
                },
                {
                    "sent": "If it should be discouraged at all.",
                    "label": 0
                },
                {
                    "sent": "Did you find a similar attitude in your regular interactions with FDA?",
                    "label": 0
                },
                {
                    "sent": "So, um.",
                    "label": 0
                },
                {
                    "sent": "The short answer is no, but with the qualification so nobody's ever accused me of not understanding sampling variability, and in fact I incorporate sampling of variability in the predictive distributions.",
                    "label": 0
                },
                {
                    "sent": "You know, in the usual way, there is the sampling variability that we all know and love because we wouldn't have an occupation without it.",
                    "label": 0
                },
                {
                    "sent": "But then there is this.",
                    "label": 0
                },
                {
                    "sent": "The variability in the parameter, the usual way that people do these things as a condition on.",
                    "label": 0
                },
                {
                    "sent": "Parameters we can we don't have to condition on parameters.",
                    "label": 0
                },
                {
                    "sent": "We condition on what we know and we don't know the parameters.",
                    "label": 0
                },
                {
                    "sent": "But there is a kind of variability that they do worry about.",
                    "label": 0
                },
                {
                    "sent": "And that is if you're doing adaptation, let's say adaptive randomization and the patient population changes so that at some point you're looking at the, you know the severe patients, but then you started to look at the less severe patients, so there's variability in the way in which you accrue patients, and for some reason you've given up on one of the arms.",
                    "label": 0
                },
                {
                    "sent": "And then you using, you know the rest for the.",
                    "label": 0
                },
                {
                    "sent": "There can be biases associated with that.",
                    "label": 0
                },
                {
                    "sent": "Usually I mean that we have investigated that buyers.",
                    "label": 0
                },
                {
                    "sent": "It's not usually great and usually the using that word too much.",
                    "label": 0
                },
                {
                    "sent": "There's covariate information that you can take into account so that you can correlate what is happening to the patient overtime that you're seeing different patient populations as measured by aggressiveness of disease or stage of disease or something.",
                    "label": 0
                },
                {
                    "sent": "So I'm not sure what you meant by sampling variability.",
                    "label": 0
                },
                {
                    "sent": "But it looks like I answered your question.",
                    "label": 0
                },
                {
                    "sent": "Or it looks like you want to go out and get some wine or something.",
                    "label": 0
                },
                {
                    "sent": "Thank you.",
                    "label": 0
                },
                {
                    "sent": "That's right bus, but so let's thank Don again, thank you.",
                    "label": 0
                }
            ]
        }
    }
}